<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Online Pharmacy US</title>
	<atom:link href="http://medsnetic.com/blog/feed/" rel="self" type="application/rss+xml" />
	<link>http://medsnetic.com/blog</link>
	<description>Viagra, Xanax, Cialis, Phentermine, Levitra</description>
	<lastBuildDate>Fri, 30 Jul 2010 08:13:41 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>The Importance of Different Frequency Bands in Predicting Subcutaneous Glucose Concentration in Type 1 Diabetic Patients</title>
		<link>http://medsnetic.com/blog/2010/07/30/the-importance-of-different-frequency-bands-in-predicting-subcutaneous-glucose-concentration-in-type-1-diabetic-patients/</link>
		<comments>http://medsnetic.com/blog/2010/07/30/the-importance-of-different-frequency-bands-in-predicting-subcutaneous-glucose-concentration-in-type-1-diabetic-patients/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 08:13:41 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280474201</guid>
		<description><![CDATA[We investigated the relative importance and predictive power of different frequency bands of subcutaneous glucose signals for the short-term (0&#x2013;50 min) forecasting of glucose concentrations in type 1 diabetic patients with data-driven autoregressive (AR) models. The study data consisted of minute-by-minute glucose signals collected from nine deidentified patients over a five-day period using continuous glucose monitoring devices. AR models were developed using single and pairwise combinations of frequency bands of the glucose signal and compared with a reference model including all bands. The results suggest that: for open-loop applications, there is no need to explicitly represent exogenous inputs, such as meals and insulin intake, in AR models; models based on a single-frequency b... ]]></description>
			<content:encoded><![CDATA[<p>We investigated the relative importance and predictive power of different frequency bands of subcutaneous glucose signals for the short-term (0&#x2013;50 min) forecasting of glucose concentrations in type 1 diabetic patients with data-driven autoregressive (AR) models. The study data consisted of minute-by-minute glucose signals collected from nine deidentified patients over a five-day period using continuous glucose monitoring devices. AR models were developed using single and pairwise combinations of frequency bands of the glucose signal and compared with a reference model including all bands. The results suggest that: for open-loop applications, there is no need to explicitly represent exogenous inputs, such as meals and insulin intake, in AR models; models based on a single-frequency b&#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/30/the-importance-of-different-frequency-bands-in-predicting-subcutaneous-glucose-concentration-in-type-1-diabetic-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Popular Diabetes Drugs Associated With Fractures In Type 2 Diabetic Patients</title>
		<link>http://medsnetic.com/blog/2010/07/30/popular-diabetes-drugs-associated-with-fractures-in-type-2-diabetic-patients/</link>
		<comments>http://medsnetic.com/blog/2010/07/30/popular-diabetes-drugs-associated-with-fractures-in-type-2-diabetic-patients/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 06:16:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280469600</guid>
		<description><![CDATA[Postmenopausal women with diabetes taking thiazolidinediones (TZDS), including rosiglitazone and pioglitazone, may be at increased risk for fractures according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology &#038; Metabolism (JCEM). Men with diabetes taking both loop diuretics and TZDs may also be at increased risk of fractures... (Source: Health News from Medical News Today) ]]></description>
			<content:encoded><![CDATA[<p>Postmenopausal women with diabetes taking thiazolidinediones (TZDS), including rosiglitazone and pioglitazone, may be at increased risk for fractures according to a new study accepted for publication in The Endocrine Society&#8217;s Journal of Clinical Endocrinology &#038; Metabolism (JCEM). Men with diabetes taking both loop diuretics and TZDs may also be at increased risk of fractures&#8230; (Source: Health News from Medical News Today) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/30/popular-diabetes-drugs-associated-with-fractures-in-type-2-diabetic-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Novel Weight-Loss Combo May Lower BP</title>
		<link>http://medsnetic.com/blog/2010/07/30/novel-weight-loss-combo-may-lower-bp-2/</link>
		<comments>http://medsnetic.com/blog/2010/07/30/novel-weight-loss-combo-may-lower-bp-2/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 04:31:05 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Phentermine]]></category>
		<category><![CDATA[Combo]]></category>
		<category><![CDATA[loss]]></category>
		<category><![CDATA[Lower]]></category>
		<category><![CDATA[Novel]]></category>
		<category><![CDATA[weight]]></category>

		<guid isPermaLink="false">http://medsnetic.com/blog/2010/07/30/novel-weight-loss-combo-may-lower-bp-2/</guid>
		<description><![CDATA[ Major Finding: In patients on the highest dose of phentermine plus controlled-release topiramate, systolic BP reductions were significantly lower than with placebo: 3.4 mm Hg after 28 weeks in EQUATE, 3.8 mm Hg after 56 weeks in EQUIP, and 3.2 mm Hg after 56 weeks in CONQUER. (Source: Clinical Endocrinology News)
]]></description>
			<content:encoded><![CDATA[<p> Major Finding: In patients on the highest dose of <b>phentermine</b> plus controlled-release topiramate, systolic BP reductions were significantly lower than with placebo: 3.4 mm Hg after 28 weeks in EQUATE, 3.8 mm Hg after 56 weeks in EQUIP, and 3.2 mm Hg after 56 weeks in CONQUER. (Source: Clinical Endocrinology News)</p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/30/novel-weight-loss-combo-may-lower-bp-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ENDO: Novel Drug Combo May Aid in Weight Loss (CME/CE)</title>
		<link>http://medsnetic.com/blog/2010/07/30/endo-novel-drug-combo-may-aid-in-weight-loss-cmece-2/</link>
		<comments>http://medsnetic.com/blog/2010/07/30/endo-novel-drug-combo-may-aid-in-weight-loss-cmece-2/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 01:12:20 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Phentermine]]></category>
		<category><![CDATA[Combo]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[ENDO]]></category>
		<category><![CDATA[loss]]></category>
		<category><![CDATA[Novel]]></category>
		<category><![CDATA[weight]]></category>

		<guid isPermaLink="false">http://medsnetic.com/blog/2010/07/30/endo-novel-drug-combo-may-aid-in-weight-loss-cmece-2/</guid>
		<description><![CDATA[ SAN DIEGO (MedPage Today) &#8212; A combination of phentermine and topiramate (Qnexa) appears to induce weight loss and a decrease in metabolic risk parameters for cardiovascular disease in obese patients, researchers reported here. (Source: MedPage Today Endocrinology)
   MedWorm Message:   Register for MedMatcha, MedWorm&#8217;s m edical advertising network, and receive $5 [...]]]></description>
			<content:encoded><![CDATA[<p> SAN DIEGO (MedPage Today) &#8212; A combination of <b>phentermine</b> and topiramate (Qnexa) appears to induce weight loss and a decrease in metabolic risk parameters for cardiovascular disease in obese patients, researchers reported here. (Source: MedPage Today Endocrinology)
<p>  <i> MedWorm Message: </i>  Register for MedMatcha, MedWorm&#8217;s m edical advertising network, and receive $5 free advertising. </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/30/endo-novel-drug-combo-may-aid-in-weight-loss-cmece-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Unusual Ways to Quit Smoking</title>
		<link>http://medsnetic.com/blog/2010/07/29/unusual-ways-to-quit-smoking/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/unusual-ways-to-quit-smoking/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 20:23:17 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280432177</guid>
		<description><![CDATA[WebMD discusses ways you can kick the smoking habit for good. (Source: WebMD Health) ]]></description>
			<content:encoded><![CDATA[<p>WebMD discusses ways you can kick the smoking habit for good. (Source: WebMD Health) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/unusual-ways-to-quit-smoking/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Just Drop It: The One-Size-Fits-All Approach to Blood Sugar Control, That Is</title>
		<link>http://medsnetic.com/blog/2010/07/29/just-drop-it-the-one-size-fits-all-approach-to-blood-sugar-control-that-is/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/just-drop-it-the-one-size-fits-all-approach-to-blood-sugar-control-that-is/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 20:19:17 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280434637</guid>
		<description><![CDATA[July 29, 2010 (EurekAlert) - Aggressive blood sugar control does not improve survival in diabetic patients with kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results suggest that physicians should individualize blood sugar targets for these patients and not rely on recommendations based on studies in the general population.
read more (Source: Diabetes News from dLife.com) ]]></description>
			<content:encoded><![CDATA[<p>July 29, 2010 (EurekAlert) &#8211; Aggressive blood sugar control does not improve survival in diabetic patients with kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results suggest that physicians should individualize blood sugar targets for these patients and not rely on recommendations based on studies in the general population.<br />
read more (Source: Diabetes News from dLife.com) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/just-drop-it-the-one-size-fits-all-approach-to-blood-sugar-control-that-is/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Short-term type 1 diabetes alters the mechanism of endothelium-dependent relaxation in the rat carotid artery</title>
		<link>http://medsnetic.com/blog/2010/07/29/short-term-type-1-diabetes-alters-the-mechanism-of-endothelium-dependent-relaxation-in-the-rat-carotid-artery/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/short-term-type-1-diabetes-alters-the-mechanism-of-endothelium-dependent-relaxation-in-the-rat-carotid-artery/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 20:16:15 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280433735</guid>
		<description><![CDATA[The aim of the present study was to examine the effect of an early stage of streptozotocin-induced diabetes on the mechanism(s) of endothelium-dependent relaxation. Diabetes was induced by a single injection of streptozotocin (48 mg/kg iv), and the ACh-induced relaxation of rat carotid arteries was examined 6 wk later. A diabetes-induced increase in superoxide levels, determined by L-012-induced chemiluminescence, from carotid arteries was associated with endothelial nitric oxide (NO) synthase (eNOS) uncoupling and increased catalytic subunit of NADPH oxidase expression. The sensitivity and maximum response to ACh were similar in normal and diabetic rats despite a decrease in NO release detected by 4-amino-5-methylamino-2',7'-difluorofluorescein. In normal rats, N-nitro-l-arginine (100 &#038;mi... ]]></description>
			<content:encoded><![CDATA[<p>The aim of the present study was to examine the effect of an early stage of streptozotocin-induced diabetes on the mechanism(s) of endothelium-dependent relaxation. Diabetes was induced by a single injection of streptozotocin (48 mg/kg iv), and the ACh-induced relaxation of rat carotid arteries was examined 6 wk later. A diabetes-induced increase in superoxide levels, determined by L-012-induced chemiluminescence, from carotid arteries was associated with endothelial nitric oxide (NO) synthase (eNOS) uncoupling and increased catalytic subunit of NADPH oxidase expression. The sensitivity and maximum response to ACh were similar in normal and diabetic rats despite a decrease in NO release detected by 4-amino-5-methylamino-2&#8242;,7&#8242;-difluorofluorescein. In normal rats, N-nitro-l-arginine (100 &#038;mi&#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/short-term-type-1-diabetes-alters-the-mechanism-of-endothelium-dependent-relaxation-in-the-rat-carotid-artery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mitochondrial dysfunction in the type 2 diabetic heart is associated with alterations in spatially distinct mitochondrial proteomes</title>
		<link>http://medsnetic.com/blog/2010/07/29/mitochondrial-dysfunction-in-the-type-2-diabetic-heart-is-associated-with-alterations-in-spatially-distinct-mitochondrial-proteomes/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/mitochondrial-dysfunction-in-the-type-2-diabetic-heart-is-associated-with-alterations-in-spatially-distinct-mitochondrial-proteomes/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 20:03:16 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280433736</guid>
		<description><![CDATA[Cardiac complications and heart failure are the leading cause of death in type 2 diabetic patients. Mitochondrial dysfunction is central in the pathogenesis of the type 2 diabetic heart. However, it is unclear whether this dysfunction is specific for a particular subcellular region. The purpose of this study was to determine whether mitochondrial dysfunction in the type 2 diabetic heart is specific to a spatially distinct subset of mitochondria. We investigated mitochondrial morphology, function, and proteomic composition of subsarcolemmal mitochondria (SSM) and interfibrillar mitochondria (IFM) in 18-wk-old db/db mice. Oxidative damage was assessed in subpopulations through the measurement of lipid peroxidation byproducts and nitrotyrosine residues. Proteomic profiles and posttranslationa... ]]></description>
			<content:encoded><![CDATA[<p>Cardiac complications and heart failure are the leading cause of death in type 2 diabetic patients. Mitochondrial dysfunction is central in the pathogenesis of the type 2 diabetic heart. However, it is unclear whether this dysfunction is specific for a particular subcellular region. The purpose of this study was to determine whether mitochondrial dysfunction in the type 2 diabetic heart is specific to a spatially distinct subset of mitochondria. We investigated mitochondrial morphology, function, and proteomic composition of subsarcolemmal mitochondria (SSM) and interfibrillar mitochondria (IFM) in 18-wk-old db/db mice. Oxidative damage was assessed in subpopulations through the measurement of lipid peroxidation byproducts and nitrotyrosine residues. Proteomic profiles and posttranslationa&#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/mitochondrial-dysfunction-in-the-type-2-diabetic-heart-is-associated-with-alterations-in-spatially-distinct-mitochondrial-proteomes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy.</title>
		<link>http://medsnetic.com/blog/2010/07/29/complex-hyperplasia-with-and-without-atypia-clinical-outcomes-and-implications-of-progestin-therapy/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/complex-hyperplasia-with-and-without-atypia-clinical-outcomes-and-implications-of-progestin-therapy/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 19:43:14 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280429294</guid>
		<description><![CDATA[CONCLUSION:: Endometrial carcinoma risk is diminished approximately threefold to fivefold in women diagnosed with complex or atypical endometrial hyperplasia and dispensed progestin; hysterectomy risk is also decreased. LEVEL OF EVIDENCE:: II. PMID: 20664397 [PubMed - in process] (Source: Obstetrics and Gynecology) ]]></description>
			<content:encoded><![CDATA[<p>CONCLUSION:: Endometrial carcinoma risk is diminished approximately threefold to fivefold in women diagnosed with complex or atypical endometrial hyperplasia and dispensed progestin; hysterectomy risk is also decreased. LEVEL OF EVIDENCE:: II. PMID: 20664397 [PubMed - in process] (Source: Obstetrics and Gynecology) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/complex-hyperplasia-with-and-without-atypia-clinical-outcomes-and-implications-of-progestin-therapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Primary iliopsoas abscess and pregnancy.</title>
		<link>http://medsnetic.com/blog/2010/07/29/primary-iliopsoas-abscess-and-pregnancy-2/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/primary-iliopsoas-abscess-and-pregnancy-2/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 19:24:42 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280429202</guid>
		<description><![CDATA[CONCLUSION:: Primary iliopsoas abscess should be considered in the differential diagnosis of low-back pain among high-risk pregnant women. Clinicians should be vigilant in identifying high-risk factors and aggressive in treating this rare and potentially fatal complication. PMID: 20664425 [PubMed - in process] (Source: Obstetrics and Gynecology) ]]></description>
			<content:encoded><![CDATA[<p>CONCLUSION:: Primary iliopsoas abscess should be considered in the differential diagnosis of low-back pain among high-risk pregnant women. Clinicians should be vigilant in identifying high-risk factors and aggressive in treating this rare and potentially fatal complication. PMID: 20664425 [PubMed - in process] (Source: Obstetrics and Gynecology) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/primary-iliopsoas-abscess-and-pregnancy-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Jarisch-herxheimer reaction triggered by group B streptococcus intrapartum antibiotic prophylaxis.</title>
		<link>http://medsnetic.com/blog/2010/07/29/jarisch-herxheimer-reaction-triggered-by-group-b-streptococcus-intrapartum-antibiotic-prophylaxis/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/jarisch-herxheimer-reaction-triggered-by-group-b-streptococcus-intrapartum-antibiotic-prophylaxis/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 19:22:16 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280429116</guid>
		<description><![CDATA[CONCLUSION:: Beta-lactam antibiotics for group B Streptococcus intrapartum prophylaxis can trigger the Jarisch-Herxhemer reaction in patients with undiagnosed syphilis resulting in unanticipated changes in maternal and fetal well-being. PMID: 20664452 [PubMed - in process] (Source: Obstetrics and Gynecology) ]]></description>
			<content:encoded><![CDATA[<p>CONCLUSION:: Beta-lactam antibiotics for group B Streptococcus intrapartum prophylaxis can trigger the Jarisch-Herxhemer reaction in patients with undiagnosed syphilis resulting in unanticipated changes in maternal and fetal well-being. PMID: 20664452 [PubMed - in process] (Source: Obstetrics and Gynecology) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/jarisch-herxheimer-reaction-triggered-by-group-b-streptococcus-intrapartum-antibiotic-prophylaxis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Propylthiouracil-induced agranulocytosis in the third trimester of pregnancy.</title>
		<link>http://medsnetic.com/blog/2010/07/29/propylthiouracil-induced-agranulocytosis-in-the-third-trimester-of-pregnancy/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/propylthiouracil-induced-agranulocytosis-in-the-third-trimester-of-pregnancy/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 19:18:38 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280429198</guid>
		<description><![CDATA[CONCLUSION:: In circumstances in which thionamides are contraindicated, management options of hyperthyroidism in pregnancy are limited. The proximity to term in the third trimester makes expectant management an attractive approach when maternal thyroid indices are stable, allowing for a choice of postpartum therapies without the worry of fetal implications. However, this strategy carries risks, and thyroidectomy in the third trimester can be a safe alternative. PMID: 20664427 [PubMed - in process] (Source: Obstetrics and Gynecology) ]]></description>
			<content:encoded><![CDATA[<p>CONCLUSION:: In circumstances in which thionamides are contraindicated, management options of hyperthyroidism in pregnancy are limited. The proximity to term in the third trimester makes expectant management an attractive approach when maternal thyroid indices are stable, allowing for a choice of postpartum therapies without the worry of fetal implications. However, this strategy carries risks, and thyroidectomy in the third trimester can be a safe alternative. PMID: 20664427 [PubMed - in process] (Source: Obstetrics and Gynecology) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/propylthiouracil-induced-agranulocytosis-in-the-third-trimester-of-pregnancy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Spontaneous Methicillin-Resistant Staphylococcus aureus Epidural Abscess in Pregnancy.</title>
		<link>http://medsnetic.com/blog/2010/07/29/spontaneous-methicillin-resistant-staphylococcus-aureus-epidural-abscess-in-pregnancy/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/spontaneous-methicillin-resistant-staphylococcus-aureus-epidural-abscess-in-pregnancy/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 19:14:19 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280429179</guid>
		<description><![CDATA[CONCLUSION:: Spontaneous epidural abscess is a rare condition and diagnosis is often delayed. The finding of Horner syndrome led to imaging of the cervical spine and diagnosis of epidural abscess. Early intervention resulted in resolution of neurologic symptoms and a successful pregnancy outcome. PMID: 20664432 [PubMed - in process] (Source: Obstetrics and Gynecology) ]]></description>
			<content:encoded><![CDATA[<p>CONCLUSION:: Spontaneous epidural abscess is a rare condition and diagnosis is often delayed. The finding of Horner syndrome led to imaging of the cervical spine and diagnosis of epidural abscess. Early intervention resulted in resolution of neurologic symptoms and a successful pregnancy outcome. PMID: 20664432 [PubMed - in process] (Source: Obstetrics and Gynecology) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/spontaneous-methicillin-resistant-staphylococcus-aureus-epidural-abscess-in-pregnancy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Primary psoas muscle abscess after an uncomplicated spontaneous vaginal delivery.</title>
		<link>http://medsnetic.com/blog/2010/07/29/primary-psoas-muscle-abscess-after-an-uncomplicated-spontaneous-vaginal-delivery/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/primary-psoas-muscle-abscess-after-an-uncomplicated-spontaneous-vaginal-delivery/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 18:57:46 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280429206</guid>
		<description><![CDATA[CONCLUSION:: Prompt recognition of and subsequent effective treatment for a psoas abscess are crucial to avoid potential long-term morbidity and even mortality. PMID: 20664424 [PubMed - in process] (Source: Obstetrics and Gynecology) ]]></description>
			<content:encoded><![CDATA[<p>CONCLUSION:: Prompt recognition of and subsequent effective treatment for a psoas abscess are crucial to avoid potential long-term morbidity and even mortality. PMID: 20664424 [PubMed - in process] (Source: Obstetrics and Gynecology) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/primary-psoas-muscle-abscess-after-an-uncomplicated-spontaneous-vaginal-delivery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Primary iliopsoas abscess and pregnancy.</title>
		<link>http://medsnetic.com/blog/2010/07/29/primary-iliopsoas-abscess-and-pregnancy/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/primary-iliopsoas-abscess-and-pregnancy/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 18:49:42 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280429202</guid>
		<description><![CDATA[CONCLUSION:: Primary iliopsoas abscess should be considered in the differential diagnosis of low-back pain among high-risk pregnant women. Clinicians should be vigilant in identifying high-risk factors and aggressive in treating this rare and potentially fatal complication. PMID: 20664425 [PubMed - in process] (Source: Obstetrics and Gynecology) ]]></description>
			<content:encoded><![CDATA[<p>CONCLUSION:: Primary iliopsoas abscess should be considered in the differential diagnosis of low-back pain among high-risk pregnant women. Clinicians should be vigilant in identifying high-risk factors and aggressive in treating this rare and potentially fatal complication. PMID: 20664425 [PubMed - in process] (Source: Obstetrics and Gynecology) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/primary-iliopsoas-abscess-and-pregnancy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Health Policy: Encouraging Friendships?</title>
		<link>http://medsnetic.com/blog/2010/07/29/new-health-policy-encouraging-friendships-2/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/new-health-policy-encouraging-friendships-2/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 15:47:04 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280418064</guid>
		<description><![CDATA[Having good social relationships - friends, marriage or children - may be every bit as important to a healthy lifespan as quitting smoking, losing weight or taking certain medications, U.S. researchers reported on Tuesday. Reuters Health Information (Source: Medscape Medical News Headlines) ]]></description>
			<content:encoded><![CDATA[<p>Having good social relationships &#8211; friends, marriage or children &#8211; may be every bit as important to a healthy lifespan as quitting smoking, losing weight or taking certain medications, U.S. researchers reported on Tuesday. Reuters Health Information (Source: Medscape Medical News Headlines) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/new-health-policy-encouraging-friendships-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Company Health Plans May Increasingly Demand Proof Family Is Family</title>
		<link>http://medsnetic.com/blog/2010/07/29/company-health-plans-may-increasingly-demand-proof-family-is-family/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/company-health-plans-may-increasingly-demand-proof-family-is-family/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 11:41:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280401200</guid>
		<description><![CDATA[CNNMoney: "Think your whole family is covered by your company health plan? Get ready to prove they're actually your kin." Under the new health overhaul law, starting next year "employers will have to provide coverage for dependents of employees [until] age 26. That will further inflate coverage costs for companies at a time when employers are already bracing for a 9% jump in their health care plan expenditures in 2011... (Source: Health News from Medical News Today) ]]></description>
			<content:encoded><![CDATA[<p>CNNMoney: &#8220;Think your whole family is covered by your company health plan? Get ready to prove they&#8217;re actually your kin.&#8221; Under the new health overhaul law, starting next year &#8220;employers will have to provide coverage for dependents of employees [until] age 26. That will further inflate coverage costs for companies at a time when employers are already bracing for a 9% jump in their health care plan expenditures in 2011&#8230; (Source: Health News from Medical News Today) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/company-health-plans-may-increasingly-demand-proof-family-is-family/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Abbott&#8217;s SIMCOR(R) (Niacin Extended-Release / Simvastatin) Receives FDA Approval For New Dosage Strengths</title>
		<link>http://medsnetic.com/blog/2010/07/29/abbotts-simcorr-niacin-extended-release-simvastatin-receives-fda-approval-for-new-dosage-strengths/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/abbotts-simcorr-niacin-extended-release-simvastatin-receives-fda-approval-for-new-dosage-strengths/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 10:03:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280397600</guid>
		<description><![CDATA[Abbott received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCORÃÂ®, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin - the most commonly prescribed dose of simvastatin - with either 500 mg or 1,000 mg of niacin extended-release. SIMCOR is the first treatment to combine Abbott's proprietary niacin extended-release and simvastatin, the most commonly used statin. SIMCOR is a prescription medication used along with diet in people who cannot control their cholesterol levels by diet and exercise alone... (Source: Health News from Medical News Today) ]]></description>
			<content:encoded><![CDATA[<p>Abbott received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCORÃÂ®, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin &#8211; the most commonly prescribed dose of simvastatin &#8211; with either 500 mg or 1,000 mg of niacin extended-release. SIMCOR is the first treatment to combine Abbott&#8217;s proprietary niacin extended-release and simvastatin, the most commonly used statin. SIMCOR is a prescription medication used along with diet in people who cannot control their cholesterol levels by diet and exercise alone&#8230; (Source: Health News from Medical News Today) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/abbotts-simcorr-niacin-extended-release-simvastatin-receives-fda-approval-for-new-dosage-strengths/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>e-Cigarette Aerosol Decreases Over Time In Smoke-Out Interval, Requiring Stronger Puffs</title>
		<link>http://medsnetic.com/blog/2010/07/29/e-cigarette-aerosol-decreases-over-time-in-smoke-out-interval-requiring-stronger-puffs/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/e-cigarette-aerosol-decreases-over-time-in-smoke-out-interval-requiring-stronger-puffs/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 09:44:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280394000</guid>
		<description><![CDATA[Stronger suction is required to smoke "electronic cigarettes" - marketed as tobacco-free nicotine delivery systems - than conventional brands, with possible adverse effects on human health, researchers at the University of California, Riverside report. The researchers used a smoking machine to compare the smoking properties of eight conventional cigarettes with five e-cigarette brands. They examined the vacuum required to produce smoke (in the case of conventional cigarettes) or aerosol (in the case of e-cigarettes), and compared the density of the smoke/aerosol over time... (Source: Health News from Medical News Today) ]]></description>
			<content:encoded><![CDATA[<p>Stronger suction is required to smoke &#8220;electronic cigarettes&#8221; &#8211; marketed as tobacco-free nicotine delivery systems &#8211; than conventional brands, with possible adverse effects on human health, researchers at the University of California, Riverside report. The researchers used a smoking machine to compare the smoking properties of eight conventional cigarettes with five e-cigarette brands. They examined the vacuum required to produce smoke (in the case of conventional cigarettes) or aerosol (in the case of e-cigarettes), and compared the density of the smoke/aerosol over time&#8230; (Source: Health News from Medical News Today) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/e-cigarette-aerosol-decreases-over-time-in-smoke-out-interval-requiring-stronger-puffs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Abbott&#8217;s SIMCOR ÃÂ® ( Niacin Extended-release / Simvastatin ) Receives FDA Approval For New Dosage Strengths</title>
		<link>http://medsnetic.com/blog/2010/07/29/abbotts-simcor-a%c2%82a%c2%ae-niacin-extended-release-simvastatin-receives-fda-approval-for-new-dosage-strengths/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/abbotts-simcor-a%c2%82a%c2%ae-niacin-extended-release-simvastatin-receives-fda-approval-for-new-dosage-strengths/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 08:58:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280390400</guid>
		<description><![CDATA[Abbott (NYSE: ABT) received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCORÃÂ®, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin the most commonly prescribed dose of simvastatin with either 500 mg or 1,000 mg of niacin extended-release. SIMCOR is the first treatment to combine Abbott's proprietary niacin extended-release and simvastatin, the most commonly used statin... (Source: Health News from Medical News Today) ]]></description>
			<content:encoded><![CDATA[<p>Abbott (NYSE: ABT) received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCORÃÂ®, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin the most commonly prescribed dose of simvastatin with either 500 mg or 1,000 mg of niacin extended-release. SIMCOR is the first treatment to combine Abbott&#8217;s proprietary niacin extended-release and simvastatin, the most commonly used statin&#8230; (Source: Health News from Medical News Today) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/abbotts-simcor-a%c2%82a%c2%ae-niacin-extended-release-simvastatin-receives-fda-approval-for-new-dosage-strengths/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Global Breakthrough In Treatment Of Dementia &#8216;Within Reach&#8217; &#8211; Clinical Trial In Scotland Recruiting</title>
		<link>http://medsnetic.com/blog/2010/07/29/global-breakthrough-in-treatment-of-dementia-within-reach-clinical-trial-in-scotland-recruiting/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/global-breakthrough-in-treatment-of-dementia-within-reach-clinical-trial-in-scotland-recruiting/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 07:52:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280386800</guid>
		<description><![CDATA[A Glasgow-based medical research company is leading a worldwide sleep study which could radically reduce the symptoms associated with dementia. The groundbreaking trial, conducted by CPS Research, is the first of its kind to investigate the use of sleep hormone melatonin as an add on treatment for dementia. The study is already showing remarkable initial results in volunteers from Scotland. Melatonin is the natural hormone produced at night to prepare the body for sleep and produced throughout the night to maintain sleep... (Source: Health News from Medical News Today) ]]></description>
			<content:encoded><![CDATA[<p>A Glasgow-based medical research company is leading a worldwide sleep study which could radically reduce the symptoms associated with dementia. The groundbreaking trial, conducted by CPS Research, is the first of its kind to investigate the use of sleep hormone melatonin as an add on treatment for dementia. The study is already showing remarkable initial results in volunteers from Scotland. Melatonin is the natural hormone produced at night to prepare the body for sleep and produced throughout the night to maintain sleep&#8230; (Source: Health News from Medical News Today) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/global-breakthrough-in-treatment-of-dementia-within-reach-clinical-trial-in-scotland-recruiting/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drugs Like Viagra Linked to Higher Rates of STDs</title>
		<link>http://medsnetic.com/blog/2010/07/29/drugs-like-viagra-linked-to-higher-rates-of-stds-2/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/drugs-like-viagra-linked-to-higher-rates-of-stds-2/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 07:06:05 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[VIAGRA]]></category>
		<category><![CDATA[Drugs]]></category>
		<category><![CDATA[Higher]]></category>
		<category><![CDATA[Like]]></category>
		<category><![CDATA[Linked]]></category>
		<category><![CDATA[Rates]]></category>
		<category><![CDATA[STDs]]></category>

		<guid isPermaLink="false">http://medsnetic.com/blog/2010/07/29/drugs-like-viagra-linked-to-higher-rates-of-stds-2/</guid>
		<description><![CDATA[ Title: Drugs Like Viagra Linked to Higher Rates of STDsCategory: Health NewsCreated: 7/5/2010 4:10:00 PMLast Editorial Review: 7/6/2010 (Source: MedicineNet Mens Health General)
   MedWorm Message:   Register for MedMatcha, MedWorm&#8217;s medical advertising network, and receive $5 free advertising. 
]]></description>
			<content:encoded><![CDATA[<p> Title: Drugs Like <b>Viagra</b> Linked to Higher Rates of STDsCategory: Health NewsCreated: 7/5/2010 4:10:00 PMLast Editorial Review: 7/6/2010 (Source: MedicineNet Mens Health General)
<p>  <i> MedWorm Message: </i>  Register for MedMatcha, MedWorm&#8217;s medical advertising network, and receive $5 free advertising. </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/drugs-like-viagra-linked-to-higher-rates-of-stds-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Appropriate prescribing critical to manage pain drugs</title>
		<link>http://medsnetic.com/blog/2010/07/29/appropriate-prescribing-critical-to-manage-pain-drugs/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/appropriate-prescribing-critical-to-manage-pain-drugs/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 06:58:42 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280385402</guid>
		<description><![CDATA[Stronger opioids such as morphine, hydromorphone, oxymorphone, methadone, levorphanol, fentanyl and oxycodone are generally used for treatment of moderate to severe pain. (Source: Managed Healthcare Executive Magazine Online) ]]></description>
			<content:encoded><![CDATA[<p>Stronger opioids such as morphine, hydromorphone, oxymorphone, methadone, levorphanol, fentanyl and oxycodone are generally used for treatment of moderate to severe pain. (Source: Managed Healthcare Executive Magazine Online) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/appropriate-prescribing-critical-to-manage-pain-drugs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>African Leaders Agree on Ways Forward on Maternal and Child Health &#8211; 27 July 2010</title>
		<link>http://medsnetic.com/blog/2010/07/29/african-leaders-agree-on-ways-forward-on-maternal-and-child-health-27-july-2010-2/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/african-leaders-agree-on-ways-forward-on-maternal-and-child-health-27-july-2010-2/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 06:31:49 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280384689</guid>
		<description><![CDATA[KAMPALA, Uganda &#8212; The high-level debate which opened in Kampala, Uganda, yesterday on &#8220;Promoting Maternal, Infant and Child Health and Development in Africa, ended this evening with an agreement by Africa&#8217;s leaders on an action plan to kick-start the effective implementation of existing resolutions and decisions on maternal, infant and child health in the continent. (Source: UNFPA News) ]]></description>
			<content:encoded><![CDATA[<p>KAMPALA, Uganda &mdash; The high-level debate which opened in Kampala, Uganda, yesterday on &ldquo;Promoting Maternal, Infant and Child Health and Development in Africa, ended this evening with an agreement by Africa&rsquo;s leaders on an action plan to kick-start the effective implementation of existing resolutions and decisions on maternal, infant and child health in the continent. (Source: UNFPA News) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/african-leaders-agree-on-ways-forward-on-maternal-and-child-health-27-july-2010-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Antigenics Presents Positive, Top Line Data From Phase I Herpes Clinical Trial</title>
		<link>http://medsnetic.com/blog/2010/07/29/antigenics-presents-positive-top-line-data-from-phase-i-herpes-clinical-trial-2/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/antigenics-presents-positive-top-line-data-from-phase-i-herpes-clinical-trial-2/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 06:17:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280383200</guid>
		<description><![CDATA[Antigenics (NASDAQ: AGEN) announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2 (HSV-2), the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells. "I believe these data represent the first finding of their kind in genital herpes treatments-showing a vaccine, AG-707, elicits both CD4+ and CD8+ T-cell responses in humans," said David Koelle, M.D... (Source: Health News from Medical News Today) ]]></description>
			<content:encoded><![CDATA[<p>Antigenics (NASDAQ: AGEN) announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2 (HSV-2), the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells. &#8220;I believe these data represent the first finding of their kind in genital herpes treatments-showing a vaccine, AG-707, elicits both CD4+ and CD8+ T-cell responses in humans,&#8221; said David Koelle, M.D&#8230; (Source: Health News from Medical News Today) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/antigenics-presents-positive-top-line-data-from-phase-i-herpes-clinical-trial-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmaceutical drug contamination of waterways threatens life on our planet</title>
		<link>http://medsnetic.com/blog/2010/07/29/pharmaceutical-drug-contamination-of-waterways-threatens-life-on-our-planet/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/pharmaceutical-drug-contamination-of-waterways-threatens-life-on-our-planet/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 06:12:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280383200</guid>
		<description><![CDATA[This study was the first national-scale evaluation of pharmaceutical drug contamination in streams, and roughly 80 percent of the streams tested were found to be contaminated as well.In 2008, an AP investigation found that at least 46 million Americans are drinking water contaminated with trace amounts of pharmaceuticals. Even though every city tested has its water treated and "purified" prior to being delivered to the public, trace amounts of pharmaceutical drugs are making their way through to the tap. (Since not all major metropolitan areas were tested, the number of people affected is likely far higher than what was reported by AP.)In spite of all this, water quality reports don't disclose the levels of pharmaceuticals found in tap water. Since the EPA and FDA have failed to establish ... ]]></description>
			<content:encoded><![CDATA[<p>This study was the first national-scale evaluation of pharmaceutical drug contamination in streams, and roughly 80 percent of the streams tested were found to be contaminated as well.In 2008, an AP investigation found that at least 46 million Americans are drinking water contaminated with trace amounts of pharmaceuticals. Even though every city tested has its water treated and &#8220;purified&#8221; prior to being delivered to the public, trace amounts of pharmaceutical drugs are making their way through to the tap. (Since not all major metropolitan areas were tested, the number of people affected is likely far higher than what was reported by AP.)In spite of all this, water quality reports don&#8217;t disclose the levels of pharmaceuticals found in tap water. Since the EPA and FDA have failed to establish &#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/pharmaceutical-drug-contamination-of-waterways-threatens-life-on-our-planet/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Regional Wetlands Action Plan for the Pacific Islands</title>
		<link>http://medsnetic.com/blog/2010/07/29/regional-wetlands-action-plan-for-the-pacific-islands/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/regional-wetlands-action-plan-for-the-pacific-islands/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 05:53:15 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280380515</guid>
		<description><![CDATA[Funding Opportunity Number: RAMSAR2010-2 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EnvironmentCFDA Number: 15.640Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name DOI-FWS (Source: Grants.gov) ]]></description>
			<content:encoded><![CDATA[<p>Funding Opportunity Number: RAMSAR2010-2 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EnvironmentCFDA Number: 15.640Eligible Applicants Others (see text field entitled &#8220;Additional Information on Eligibility&#8221; for clarification)Agency Name DOI-FWS (Source: Grants.gov) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/regional-wetlands-action-plan-for-the-pacific-islands/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Effect of centchroman coadministration on the pharmacokinetics of metformin in rats</title>
		<link>http://medsnetic.com/blog/2010/07/29/effect-of-centchroman-coadministration-on-the-pharmacokinetics-of-metformin-in-rats/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/effect-of-centchroman-coadministration-on-the-pharmacokinetics-of-metformin-in-rats/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 05:34:48 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280378808</guid>
		<description><![CDATA[Conclusions : The results indicate that centchroman coadministration increases the rate but not the extent of absorption of metformin in rats. However, it does not seem to alter the pharmacokinetics of metformin to clinically significant levels. (Source: Indian Journal of Pharmacology) ]]></description>
			<content:encoded><![CDATA[<p>Conclusions : The results indicate that centchroman coadministration increases the rate but not the extent of absorption of metformin in rats. However, it does not seem to alter the pharmacokinetics of metformin to clinically significant levels. (Source: Indian Journal of Pharmacology) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/effect-of-centchroman-coadministration-on-the-pharmacokinetics-of-metformin-in-rats/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prevalence of multidrug-resistant organisms recovered at a military burn center</title>
		<link>http://medsnetic.com/blog/2010/07/29/prevalence-of-multidrug-resistant-organisms-recovered-at-a-military-burn-center/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/prevalence-of-multidrug-resistant-organisms-recovered-at-a-military-burn-center/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 05:05:44 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280377904</guid>
		<description><![CDATA[Abstract: Infections caused by multidrug-resistant (MDR) pathogens are associated with significant morbidity and mortality in patients with burn injuries. We performed a 6-year antibiotic susceptibility records review from January 2003 to December 2008 to assess the prevalence of MDR isolates by pathogen at the US Army Institute of Surgical Research Burn Center. During the study period Acinetobacter baumannii (780 isolates [22%]) was the most prevalent organism recovered, followed by Pseudomonas aeruginosa (703 isolates [20%]), Klebsiella pneumoniae (695 isolates [20%]), and Staphylococcus aureus (469 isolates [13%]). MDR prevalence rates among these isolates were A. baumannii 53%, methicillin-resistant S. aureus (MRSA) 34%, K. pneumoniae 17% and P. aeruginosa 15%. Two isolates, 1 A. bauma... ]]></description>
			<content:encoded><![CDATA[<p>Abstract: Infections caused by multidrug-resistant (MDR) pathogens are associated with significant morbidity and mortality in patients with burn injuries. We performed a 6-year antibiotic susceptibility records review from January 2003 to December 2008 to assess the prevalence of MDR isolates by pathogen at the US Army Institute of Surgical Research Burn Center. During the study period Acinetobacter baumannii (780 isolates [22%]) was the most prevalent organism recovered, followed by Pseudomonas aeruginosa (703 isolates [20%]), Klebsiella pneumoniae (695 isolates [20%]), and Staphylococcus aureus (469 isolates [13%]). MDR prevalence rates among these isolates were A. baumannii 53%, methicillin-resistant S. aureus (MRSA) 34%, K. pneumoniae 17% and P. aeruginosa 15%. Two isolates, 1 A. bauma&#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/prevalence-of-multidrug-resistant-organisms-recovered-at-a-military-burn-center/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Contribution of bacterial and viral infections to attributable mortality in patients with severe burns: An autopsy series</title>
		<link>http://medsnetic.com/blog/2010/07/29/contribution-of-bacterial-and-viral-infections-to-attributable-mortality-in-patients-with-severe-burns-an-autopsy-series/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/contribution-of-bacterial-and-viral-infections-to-attributable-mortality-in-patients-with-severe-burns-an-autopsy-series/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 05:00:40 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280377900</guid>
		<description><![CDATA[This study is a retrospective review of all autopsy reports from patients with severe thermal burns treated at the US Army Institute of Research (USAISR) burn unit over 12 years. The review focused on those patients with death attributed to a bacterial or viral cause by autopsy report. Of 3751 admissions, 228 patients died with 97 undergoing autopsy. Death was attributed to bacteria for 27 patients and to virus for 5 patients. Bacterial pathogens associated with mortality included Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus. This association with mortality was independent of % total body surface area burn, % full-thickness burn, inhalation injury, and day of death post-burn. Bloodstream infection was the most common cause of bacteria related de... ]]></description>
			<content:encoded><![CDATA[<p>This study is a retrospective review of all autopsy reports from patients with severe thermal burns treated at the US Army Institute of Research (USAISR) burn unit over 12 years. The review focused on those patients with death attributed to a bacterial or viral cause by autopsy report. Of 3751 admissions, 228 patients died with 97 undergoing autopsy. Death was attributed to bacteria for 27 patients and to virus for 5 patients. Bacterial pathogens associated with mortality included Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus. This association with mortality was independent of % total body surface area burn, % full-thickness burn, inhalation injury, and day of death post-burn. Bloodstream infection was the most common cause of bacteria related de&#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/contribution-of-bacterial-and-viral-infections-to-attributable-mortality-in-patients-with-severe-burns-an-autopsy-series/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mass casualty incidents with multiple burn victims: Rationale for a Swiss burn plan</title>
		<link>http://medsnetic.com/blog/2010/07/29/mass-casualty-incidents-with-multiple-burn-victims-rationale-for-a-swiss-burn-plan/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/mass-casualty-incidents-with-multiple-burn-victims-rationale-for-a-swiss-burn-plan/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 04:45:38 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280377898</guid>
		<description><![CDATA[Abstract: Introduction: Mass casualty incidents involving victims with severe burns pose difficult and unique problems for both rescue teams and hospitals. This paper presents an analysis of the published reports with the aim of proposing a rational model for burn rescue and hospital referral for Switzerland.Methods: Literature review including systematic searches of PubMed/Medline, reference textbooks and journals as well as landmark articles.Results: Since hospitals have limited surge capacities in the event of burn disasters, a special approach to both prehospital and hospital management of these victims is required. Specialized rescue and care can be adequately met and at all levels of needs by deploying mobile burn teams to the scene. These burn teams can bring needed skills and enhan... ]]></description>
			<content:encoded><![CDATA[<p>Abstract: Introduction: Mass casualty incidents involving victims with severe burns pose difficult and unique problems for both rescue teams and hospitals. This paper presents an analysis of the published reports with the aim of proposing a rational model for burn rescue and hospital referral for Switzerland.Methods: Literature review including systematic searches of PubMed/Medline, reference textbooks and journals as well as landmark articles.Results: Since hospitals have limited surge capacities in the event of burn disasters, a special approach to both prehospital and hospital management of these victims is required. Specialized rescue and care can be adequately met and at all levels of needs by deploying mobile burn teams to the scene. These burn teams can bring needed skills and enhan&#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/mass-casualty-incidents-with-multiple-burn-victims-rationale-for-a-swiss-burn-plan/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Tobacco Funds Shrink as Obesity Fight Intensifies</title>
		<link>http://medsnetic.com/blog/2010/07/29/tobacco-funds-shrink-as-obesity-fight-intensifies/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/tobacco-funds-shrink-as-obesity-fight-intensifies/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 04:45:26 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280376326</guid>
		<description><![CDATA[When the Robert Wood Johnson Foundation decided in 1991 to take on Joe Camel, it became the nation&#8217;s largest private funding source for fighting smoking. The foundation spent $700 million to help knock the cartoon character out of advertisements, finance research and advocacy for higher cigarette taxes and smoke-free air laws and, ultimately, to aid in reducing the nation&#8217;s smoking rate almost by half. Editor&#8217;s Note: James Marks, senior vice president and director of the Health Group at RWJF, and Matthew Myers, president of the Campaign for Tobacco-Free Kids, were quoted in this article. (Source: RWJF News Digest - Public Health) ]]></description>
			<content:encoded><![CDATA[<p>When the Robert Wood Johnson Foundation decided in 1991 to take on Joe Camel, it became the nation&rsquo;s largest private funding source for fighting smoking. The foundation spent $700 million to help knock the cartoon character out of advertisements, finance research and advocacy for higher cigarette taxes and smoke-free air laws and, ultimately, to aid in reducing the nation&rsquo;s smoking rate almost by half. Editor&rsquo;s Note: James Marks, senior vice president and director of the Health Group at RWJF, and Matthew Myers, president of the Campaign for Tobacco-Free Kids, were quoted in this article. (Source: RWJF News Digest &#8211; Public Health) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/tobacco-funds-shrink-as-obesity-fight-intensifies/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sanofi Said to Plan a Bid of $70 for Genzyme</title>
		<link>http://medsnetic.com/blog/2010/07/29/sanofi-said-to-plan-a-bid-of-70-for-genzyme/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/sanofi-said-to-plan-a-bid-of-70-for-genzyme/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 04:43:38 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280377238</guid>
		<description><![CDATA[A deal would bolster SanofiÃ¢ÂÂs drug pipeline and significantly increase its presence in biopharmaceuticals. (Source: NYT Health) ]]></description>
			<content:encoded><![CDATA[<p>A deal would bolster SanofiÃ¢ÂÂs drug pipeline and significantly increase its presence in biopharmaceuticals. (Source: NYT Health) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/sanofi-said-to-plan-a-bid-of-70-for-genzyme/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sleeping Disorders Foreshadow Dementia And ParkinsonÃ¢ÂÂs?</title>
		<link>http://medsnetic.com/blog/2010/07/29/sleeping-disorders-foreshadow-dementia-and-parkinsona%c2%a2a%c2%80a%c2%99s/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/sleeping-disorders-foreshadow-dementia-and-parkinsona%c2%a2a%c2%80a%c2%99s/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 04:27:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280376000</guid>
		<description><![CDATA[(Ivanhoe Newswire) -- Having a sleeping disorder may be warning your body of future dementia or ParkinsonÃ¢ÂÂs. (Source: Medical Headlines From Ivanhoe.com) ]]></description>
			<content:encoded><![CDATA[<p>(Ivanhoe Newswire) &#8212; Having a sleeping disorder may be warning your body of future dementia or ParkinsonÃ¢ÂÂs. (Source: Medical Headlines From Ivanhoe.com) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/sleeping-disorders-foreshadow-dementia-and-parkinsona%c2%a2a%c2%80a%c2%99s/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mechanism uncovered behind Salmonella virulence and drug susceptibility</title>
		<link>http://medsnetic.com/blog/2010/07/29/mechanism-uncovered-behind-salmonella-virulence-and-drug-susceptibility/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/mechanism-uncovered-behind-salmonella-virulence-and-drug-susceptibility/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 03:56:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280372400</guid>
		<description><![CDATA[(University of Washington) Researchers have discovered a novel mechanism in Salmonella that affects is virulence and its susceptibility to antibiotics. The mechanism changes the bacteria's production of proteins in a previously unheard of manner. It allows Salmonella to selectively change its levels of certain proteins to respond to inhospital conditions. Although the mechanism had not been recognized before, scientists found evidence of a similar mechanism in all five kingdoms of life. The mechanism appears to have been conserved throughout the course of evolution. (Source: EurekAlert! - Medicine and Health) ]]></description>
			<content:encoded><![CDATA[<p>(University of Washington) Researchers have discovered a novel mechanism in Salmonella that affects is virulence and its susceptibility to antibiotics. The mechanism changes the bacteria&#8217;s production of proteins in a previously unheard of manner. It allows Salmonella to selectively change its levels of certain proteins to respond to inhospital conditions. Although the mechanism had not been recognized before, scientists found evidence of a similar mechanism in all five kingdoms of life. The mechanism appears to have been conserved throughout the course of evolution. (Source: EurekAlert! &#8211; Medicine and Health) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/mechanism-uncovered-behind-salmonella-virulence-and-drug-susceptibility/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Abbott&#8217;s SIMCOR(R) (niacin extended-release / simvastatin) Receives FDA Approval for New Dosage Strengths</title>
		<link>http://medsnetic.com/blog/2010/07/29/abbotts-simcorr-niacin-extended-release-simvastatin-receives-fda-approval-for-new-dosage-strengths-2/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/abbotts-simcorr-niacin-extended-release-simvastatin-receives-fda-approval-for-new-dosage-strengths-2/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 03:41:22 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280374462</guid>
		<description><![CDATA[ABBOTT PARK, Ill., July 28 (HSMN NewsFeed) -- Abbott (NYSE:ABT ) today received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCOR&#174;, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simv... Biopharmaceuticals, Cardiology, FDAAbbott, SIMCOR, niacin, simvastatin, cholesterol (Source: HSMN NewsFeed) ]]></description>
			<content:encoded><![CDATA[<p>ABBOTT PARK, Ill., July 28 (HSMN NewsFeed) &#8212; Abbott (NYSE:ABT ) today received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCOR&reg;, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simv&#8230; Biopharmaceuticals, Cardiology, FDAAbbott, SIMCOR, niacin, simvastatin, cholesterol (Source: HSMN NewsFeed) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/abbotts-simcorr-niacin-extended-release-simvastatin-receives-fda-approval-for-new-dosage-strengths-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Federal Panel Endorses Ticagrelor for ACS</title>
		<link>http://medsnetic.com/blog/2010/07/29/federal-panel-endorses-ticagrelor-for-acs/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/federal-panel-endorses-ticagrelor-for-acs/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 03:13:14 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280369594</guid>
		<description><![CDATA[ADELPHI, Md. (MedPage Today) -- An FDA advisory panel has voted overwhelmingly to recommend approval of AstraZeneca's investigational antiplatelet drug ticagrelor (Brilinta), saying it appears more effective than clopidogrel (Plavix) for patients with acute coronary syndrome who will be treated either medically or with PCI. (Source: MedPage Today Public Health) ]]></description>
			<content:encoded><![CDATA[<p>ADELPHI, Md. (MedPage Today) &#8212; An FDA advisory panel has voted overwhelmingly to recommend approval of AstraZeneca&#8217;s investigational antiplatelet drug ticagrelor (Brilinta), saying it appears more effective than clopidogrel (Plavix) for patients with acute coronary syndrome who will be treated either medically or with PCI. (Source: MedPage Today Public Health) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/federal-panel-endorses-ticagrelor-for-acs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Middle school students co-author research on enzyme for activating promising disease-fighters</title>
		<link>http://medsnetic.com/blog/2010/07/29/middle-school-students-co-author-research-on-enzyme-for-activating-promising-disease-fighters/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/middle-school-students-co-author-research-on-enzyme-for-activating-promising-disease-fighters/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 02:05:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280368800</guid>
		<description><![CDATA[Two middle school students from Wisconsin joined a team of scientists who are reporting the first glimpse of the innermost structure of a key bacterial enzyme. It helps activate certain antibiotics and anti-cancer agents so that those substances do their job. (Source: ScienceDaily Headlines) ]]></description>
			<content:encoded><![CDATA[<p>Two middle school students from Wisconsin joined a team of scientists who are reporting the first glimpse of the innermost structure of a key bacterial enzyme. It helps activate certain antibiotics and anti-cancer agents so that those substances do their job. (Source: ScienceDaily Headlines) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/middle-school-students-co-author-research-on-enzyme-for-activating-promising-disease-fighters/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Evaluation of MTHFR677C&gt;T Polymorphism in Prediction and Prognosis of Esophageal Squamous Cell Carcinoma: A Case-Control Study in a Northern Indian Population.</title>
		<link>http://medsnetic.com/blog/2010/07/29/evaluation-of-mthfr677ct-polymorphism-in-prediction-and-prognosis-of-esophageal-squamous-cell-carcinoma-a-case-control-study-in-a-northern-indian-population/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/evaluation-of-mthfr677ct-polymorphism-in-prediction-and-prognosis-of-esophageal-squamous-cell-carcinoma-a-case-control-study-in-a-northern-indian-population/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 00:38:59 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280360399</guid>
		<description><![CDATA[In conclusion, MTHFR677C&#62;T polymorphism does not seem to have significant role either in susceptibility or survival of ESCC in a northern Indian population. PMID: 20661822 [PubMed - in process] (Source: Nutrition and Cancer) ]]></description>
			<content:encoded><![CDATA[<p>In conclusion, MTHFR677C&gt;T polymorphism does not seem to have significant role either in susceptibility or survival of ESCC in a northern Indian population. PMID: 20661822 [PubMed - in process] (Source: Nutrition and Cancer) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/evaluation-of-mthfr677ct-polymorphism-in-prediction-and-prognosis-of-esophageal-squamous-cell-carcinoma-a-case-control-study-in-a-northern-indian-population/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Carefusion 2200 Inc &#8211; Temno &#8211; Class 2 Recall</title>
		<link>http://medsnetic.com/blog/2010/07/29/carefusion-2200-inc-temno-class-2-recall/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/carefusion-2200-inc-temno-class-2-recall/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 00:35:07 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280361607</guid>
		<description><![CDATA[Temno Coaxial Chiba Fine Needle Aspiration; a coaxial introducer needle (20G x 15 cm) with a Chiba biopsy needle (22G x 20 cm); sterile, for single use only sets, 5 sets per case; CareFusion, McGaw Park, IL 60085 USA, Made in Dominican Republic; REF CCH2220 For use in soft tissue aspiration such as breast, kidney, liver, lung, thyroid, lymph nodes and other various soft tissue masses. It is not intended for use in the bone. (Source: Medical Device Recalls since July 07, 2006) ]]></description>
			<content:encoded><![CDATA[<p>Temno Coaxial Chiba Fine Needle Aspiration; a coaxial introducer needle (20G x 15 cm) with a Chiba biopsy needle (22G x 20 cm); sterile, for single use only sets, 5 sets per case; CareFusion, McGaw Park, IL 60085 USA, Made in Dominican Republic; REF CCH2220 For use in soft tissue aspiration such as breast, kidney, liver, lung, thyroid, lymph nodes and other various soft tissue masses. It is not intended for use in the bone. (Source: Medical Device Recalls since July 07, 2006) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/carefusion-2200-inc-temno-class-2-recall/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GST Polymorphisms Interact With Dietary Factors to Modulate Lung Cancer Risk: Study in a High-Incidence Area.</title>
		<link>http://medsnetic.com/blog/2010/07/29/gst-polymorphisms-interact-with-dietary-factors-to-modulate-lung-cancer-risk-study-in-a-high-incidence-area/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/gst-polymorphisms-interact-with-dietary-factors-to-modulate-lung-cancer-risk-study-in-a-high-incidence-area/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 00:33:56 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280360396</guid>
		<description><![CDATA[Authors: Gervasini G, Jose CS, Carrillo JA, Benitez J, Cabanillas A The aim of this study was to explore possible correlations between glutathione S-transferases (GST) polymorphisms, smoking, diet, and lung cancer susceptibility in a rural Spanish region with one of the highest incidence rates of the country. All lung cancer patients living in the area (103) and 247 matched controls were genotyped for the GST mu 1 (GSTM1) null, GST theta 1 (GSTT1) null, and GST pi 1 (GSTP1) Isoleucine (Ile) 105 valine (Val) polymorphisms and interviewed to gather information on smoking and dietary habits. Neither the presence of GST polymorphisms nor their interaction with smoking was independently associated to lung cancer risk. The intake of carotenoid-rich red and yellow vegetables was inversely ass... ]]></description>
			<content:encoded><![CDATA[<p>Authors: Gervasini G, Jose CS, Carrillo JA, Benitez J, Cabanillas A The aim of this study was to explore possible correlations between glutathione S-transferases (GST) polymorphisms, smoking, diet, and lung cancer susceptibility in a rural Spanish region with one of the highest incidence rates of the country. All lung cancer patients living in the area (103) and 247 matched controls were genotyped for the GST mu 1 (GSTM1) null, GST theta 1 (GSTT1) null, and GST pi 1 (GSTP1) Isoleucine (Ile) 105 valine (Val) polymorphisms and interviewed to gather information on smoking and dietary habits. Neither the presence of GST polymorphisms nor their interaction with smoking was independently associated to lung cancer risk. The intake of carotenoid-rich red and yellow vegetables was inversely ass&#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/gst-polymorphisms-interact-with-dietary-factors-to-modulate-lung-cancer-risk-study-in-a-high-incidence-area/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Red wine consumption not associated with reduced risk of colorectal cancer.</title>
		<link>http://medsnetic.com/blog/2010/07/29/red-wine-consumption-not-associated-with-reduced-risk-of-colorectal-cancer/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/red-wine-consumption-not-associated-with-reduced-risk-of-colorectal-cancer/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 00:30:18 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280360358</guid>
		<description><![CDATA[Authors: Chao C, Haque R, Caan BJ, Poon KY, Tseng HF, Quinn VP Red wine contains polyphenol antioxidants that inhibit colorectal cancer (CRC) development in animal studies. We investigated the effect of red wine intake on risk of CRC in the California Men's Health Study (CMHS). CMHS is a prospective, multiethnic cohort of middle-aged men who were members of the Kaiser Permanente (KP) California Health Plans and completed study questionnaires between 2002-2003. Incident CRC were identified from the health plan cancer registries through the end of 2007 (n = 287). To properly account for potential confounding by previous endoscopy screening, we restricted the primary analyses to CMHS men continuously enrolled in KP between 1998-2002 (n = 43,483 and CRC = 176). We used multivariable Cox re... ]]></description>
			<content:encoded><![CDATA[<p>Authors: Chao C, Haque R, Caan BJ, Poon KY, Tseng HF, Quinn VP Red wine contains polyphenol antioxidants that inhibit colorectal cancer (CRC) development in animal studies. We investigated the effect of red wine intake on risk of CRC in the California Men&#8217;s Health Study (CMHS). CMHS is a prospective, multiethnic cohort of middle-aged men who were members of the Kaiser Permanente (KP) California Health Plans and completed study questionnaires between 2002-2003. Incident CRC were identified from the health plan cancer registries through the end of 2007 (n = 287). To properly account for potential confounding by previous endoscopy screening, we restricted the primary analyses to CMHS men continuously enrolled in KP between 1998-2002 (n = 43,483 and CRC = 176). We used multivariable Cox re&#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/red-wine-consumption-not-associated-with-reduced-risk-of-colorectal-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Protection of p53 Wild Type Cells From Taxol by Genistein in the Combined Treatment of Lung Cancer.</title>
		<link>http://medsnetic.com/blog/2010/07/29/protection-of-p53-wild-type-cells-from-taxol-by-genistein-in-the-combined-treatment-of-lung-cancer-2/</link>
		<comments>http://medsnetic.com/blog/2010/07/29/protection-of-p53-wild-type-cells-from-taxol-by-genistein-in-the-combined-treatment-of-lung-cancer-2/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 00:17:34 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280360374</guid>
		<description><![CDATA[This study specifies the basic principles to selectively kill p53-deficient cells (H1299, FaDu) by taxol and to protect p53 wild type cells (A549) by the prior administration of structurally related flavonoids (apigenin, genistein, and quercetin). Cytotoxic and cytostatic properties of flavonoids were investigated in vitro by flow cytometry and were compared to known anticancer drugs (cisplatin, doxorubicin, etoposide). It was confirmed that doxorubicin induced growth arrest and protected A549 cells from taxol while simultaneously killing or blocking H1299 and FaDu cancer cells. It was found that doxorubicin could be successfully substituted in this way by the isoflavone genistein used at physiologically relevant concentrations. The other compounds analyzed revealed less selectivity (apige... ]]></description>
			<content:encoded><![CDATA[<p>This study specifies the basic principles to selectively kill p53-deficient cells (H1299, FaDu) by taxol and to protect p53 wild type cells (A549) by the prior administration of structurally related flavonoids (apigenin, genistein, and quercetin). Cytotoxic and cytostatic properties of flavonoids were investigated in vitro by flow cytometry and were compared to known anticancer drugs (cisplatin, doxorubicin, etoposide). It was confirmed that doxorubicin induced growth arrest and protected A549 cells from taxol while simultaneously killing or blocking H1299 and FaDu cancer cells. It was found that doxorubicin could be successfully substituted in this way by the isoflavone genistein used at physiologically relevant concentrations. The other compounds analyzed revealed less selectivity (apige&#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/29/protection-of-p53-wild-type-cells-from-taxol-by-genistein-in-the-combined-treatment-of-lung-cancer-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in kashmir valley and influence of environmental factors.</title>
		<link>http://medsnetic.com/blog/2010/07/28/association-of-xenobiotic-metabolizing-enzymes-genetic-polymorphisms-with-esophageal-cancer-in-kashmir-valley-and-influence-of-environmental-factors/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/association-of-xenobiotic-metabolizing-enzymes-genetic-polymorphisms-with-esophageal-cancer-in-kashmir-valley-and-influence-of-environmental-factors/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 23:51:02 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280360402</guid>
		<description><![CDATA[In conclusion, GSTP1val/val and CYP2E1c1c2 genotypes/c2 allele increased the risk of ESCC and EADC, respectively, in the Kashmiri population; whereas GSTM3AB genotype imparted lower risk for both ESCC and EADC. PMID: 20661821 [PubMed - in process] (Source: Nutrition and Cancer)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target ="_self">MedMatcha, MedWorm's medical advertising network</a></b>, and receive $5 free advertising.</p></div> ]]></description>
			<content:encoded><![CDATA[<p>In conclusion, GSTP1val/val and CYP2E1c1c2 genotypes/c2 allele increased the risk of ESCC and EADC, respectively, in the Kashmiri population; whereas GSTM3AB genotype imparted lower risk for both ESCC and EADC. PMID: 20661821 [PubMed - in process] (Source: Nutrition and Cancer)
<div id="medworm">
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target ="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/association-of-xenobiotic-metabolizing-enzymes-genetic-polymorphisms-with-esophageal-cancer-in-kashmir-valley-and-influence-of-environmental-factors/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Flax Seeds Can Help Breast Cancer Patients</title>
		<link>http://medsnetic.com/blog/2010/07/28/flax-seeds-can-help-breast-cancer-patients/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/flax-seeds-can-help-breast-cancer-patients/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 22:44:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280354400</guid>
		<description><![CDATA[Dear Pharmacist: My sister has breast cancer and is taking tamoxifen. She would like to take flax-seed supplements (or eat the ground-up seeds/oil), but she doesn't know if it will help or interfere with her treatment. Her doctor said it was fine but... (Source: OrlandoSentinel: Medical Research) ]]></description>
			<content:encoded><![CDATA[<p>Dear Pharmacist: My sister has breast cancer and is taking tamoxifen. She would like to take flax-seed supplements (or eat the ground-up seeds/oil), but she doesn&#8217;t know if it will help or interfere with her treatment. Her doctor said it was fine but&#8230; (Source: OrlandoSentinel: Medical Research) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/flax-seeds-can-help-breast-cancer-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Government of Canada Supports Accessibility for All Canadians</title>
		<link>http://medsnetic.com/blog/2010/07/28/government-of-canada-supports-accessibility-for-all-canadians/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/government-of-canada-supports-accessibility-for-all-canadians/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 21:45:22 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280351182</guid>
		<description><![CDATA[The Government of Canada Supports Accessibility for All Canadians - Canada's Economic Action Plan improves access to facilities, activities and services. (Source: Disabled World)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target ="_self">MedMatcha, MedWorm's medical advertising network</a></b>, and receive $5 free advertising.</p></div> ]]></description>
			<content:encoded><![CDATA[<p>The Government of Canada Supports Accessibility for All Canadians &#8211; Canada&#8217;s Economic Action Plan improves access to facilities, activities and services. (Source: Disabled World)
<div id="medworm">
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target ="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/government-of-canada-supports-accessibility-for-all-canadians/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Inducible activation of Cre recombinase in adult mice causes gastric epithelial atrophy, metaplasia, and regenerative changes in the absence of &#8220;floxed&#8221; alleles</title>
		<link>http://medsnetic.com/blog/2010/07/28/inducible-activation-of-cre-recombinase-in-adult-mice-causes-gastric-epithelial-atrophy-metaplasia-and-regenerative-changes-in-the-absence-of-floxed-alleles/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/inducible-activation-of-cre-recombinase-in-adult-mice-causes-gastric-epithelial-atrophy-metaplasia-and-regenerative-changes-in-the-absence-of-floxed-alleles/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 20:56:48 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280347308</guid>
		<description><![CDATA[The epithelium of the mammalian gastric body comprises multiple cell types replenished by a single stem cell. The adult conformation of cell lineages occurs well after birth; hence, study of genes regulating stem cell activity is facilitated by inducible systems for gene deletion. However, there is a potential pitfall involving the commonly used inducible Cre recombinase system to delete genes: we report here that induction of Cre using standard doses of tamoxifen led to marked spasmolytic polypeptide-expressing metaplasia of the stomach within days and profound atrophy of the entire epithelium with foci of hyperplasia by 2 wk even in the absence of loxP-flanked alleles. Cre induction caused genotoxicity with TdT-mediated dUTP nick-end labeling (TUNEL)-positive apoptosis (TUNEL-positive ce... ]]></description>
			<content:encoded><![CDATA[<p>The epithelium of the mammalian gastric body comprises multiple cell types replenished by a single stem cell. The adult conformation of cell lineages occurs well after birth; hence, study of genes regulating stem cell activity is facilitated by inducible systems for gene deletion. However, there is a potential pitfall involving the commonly used inducible Cre recombinase system to delete genes: we report here that induction of Cre using standard doses of tamoxifen led to marked spasmolytic polypeptide-expressing metaplasia of the stomach within days and profound atrophy of the entire epithelium with foci of hyperplasia by 2 wk even in the absence of loxP-flanked alleles. Cre induction caused genotoxicity with TdT-mediated dUTP nick-end labeling (TUNEL)-positive apoptosis (TUNEL-positive ce&#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/inducible-activation-of-cre-recombinase-in-adult-mice-causes-gastric-epithelial-atrophy-metaplasia-and-regenerative-changes-in-the-absence-of-floxed-alleles/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>WellCare gets national accreditation</title>
		<link>http://medsnetic.com/blog/2010/07/28/wellcare-gets-national-accreditation/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/wellcare-gets-national-accreditation/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 20:05:20 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280347400</guid>
		<description><![CDATA[WellCare Health Plans Inc. was awarded a full health plan accreditation for its HealthEase of Florida and WellCare of Florida subsidiaries. (WCG) (Source: bizjournals.com Health Care:Health Insurance headlines) ]]></description>
			<content:encoded><![CDATA[<p>WellCare Health Plans Inc. was awarded a full health plan accreditation for its HealthEase of Florida and WellCare of Florida subsidiaries. (WCG) (Source: bizjournals.com Health Care:Health Insurance headlines) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/wellcare-gets-national-accreditation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Report says adultBasic coverage in Pa. endangered</title>
		<link>http://medsnetic.com/blog/2010/07/28/report-says-adultbasic-coverage-in-pa-endangered/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/report-says-adultbasic-coverage-in-pa-endangered/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 19:19:48 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280343708</guid>
		<description><![CDATA[Nearly 46,000 Pennsylvanians enrolled in PennsylvaniaÃ¢ÂÂs adultBasic subsidized health insurance plan could lose their coverage next year if an agreement with the state's Blue Cross and Blue Shield providers is not renewed, according to a report issued Thursday by the Pennsylvania Budget and Policy Center and the Pennsylvania Health Access Network. (Source: bizjournals.com Health Care:Health Insurance headlines) ]]></description>
			<content:encoded><![CDATA[<p>Nearly 46,000 Pennsylvanians enrolled in PennsylvaniaÃ¢ÂÂs adultBasic subsidized health insurance plan could lose their coverage next year if an agreement with the state&#8217;s Blue Cross and Blue Shield providers is not renewed, according to a report issued Thursday by the Pennsylvania Budget and Policy Center and the Pennsylvania Health Access Network. (Source: bizjournals.com Health Care:Health Insurance headlines) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/report-says-adultbasic-coverage-in-pa-endangered/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Novartis Plans Giveaway of New ChildrenÃ¢ÂÂs Medicine</title>
		<link>http://medsnetic.com/blog/2010/07/28/novartis-plans-giveaway-of-new-childrena%c2%a2a%c2%80a%c2%99s-medicine/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/novartis-plans-giveaway-of-new-childrena%c2%a2a%c2%80a%c2%99s-medicine/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 19:10:02 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280343542</guid>
		<description><![CDATA[The Swiss drug giant will give away up to 250,000 bottles of a liquid medicine to woo parents frustrated by the recall of liquid childrenÃ¢ÂÂs Tylenol. (Source: NYT Health) ]]></description>
			<content:encoded><![CDATA[<p>The Swiss drug giant will give away up to 250,000 bottles of a liquid medicine to woo parents frustrated by the recall of liquid childrenÃ¢ÂÂs Tylenol. (Source: NYT Health) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/novartis-plans-giveaway-of-new-childrena%c2%a2a%c2%80a%c2%99s-medicine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Monitoring of Therapy in Congenital Adrenal Hyperplasia [Reviews]</title>
		<link>http://medsnetic.com/blog/2010/07/28/monitoring-of-therapy-in-congenital-adrenal-hyperplasia-reviews/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/monitoring-of-therapy-in-congenital-adrenal-hyperplasia-reviews/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 18:42:05 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280340125</guid>
		<description><![CDATA[BACKGROUND:
Congenital adrenal hyperplasia is a group of disorders caused by defects in the adrenal steroidogenic pathways. In its most common form, 21-hydroxylase deficiency, patients develop varying degrees of glucocorticoid and mineralocorticoid deficiency as well as androgen excess. Therapy is guided by monitoring clinical parameters as well as adrenal hormone and metabolite concentrations. CONTENT:
We review the evidence for clinical and biochemical parameters used in monitoring therapy for congenital adrenal hyperplasia. We discuss the utility of 24-h urine collections for pregnanetriol and 17-ketosteroids as well as serum measurements of 17-hydroxyprogesterone, androstenedione, and testosterone. In addition, we examine the added value of daily hormonal profiles obtained from saliva... ]]></description>
			<content:encoded><![CDATA[<p>BACKGROUND:<br />
Congenital adrenal hyperplasia is a group of disorders caused by defects in the adrenal steroidogenic pathways. In its most common form, 21-hydroxylase deficiency, patients develop varying degrees of glucocorticoid and mineralocorticoid deficiency as well as androgen excess. Therapy is guided by monitoring clinical parameters as well as adrenal hormone and metabolite concentrations. CONTENT:<br />
We review the evidence for clinical and biochemical parameters used in monitoring therapy for congenital adrenal hyperplasia. We discuss the utility of 24-h urine collections for pregnanetriol and 17-ketosteroids as well as serum measurements of 17-hydroxyprogesterone, androstenedione, and testosterone. In addition, we examine the added value of daily hormonal profiles obtained from saliva&#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/monitoring-of-therapy-in-congenital-adrenal-hyperplasia-reviews/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>US Medicare Issues Final Dialysis Payment Rule</title>
		<link>http://medsnetic.com/blog/2010/07/28/us-medicare-issues-final-dialysis-payment-rule/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/us-medicare-issues-final-dialysis-payment-rule/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 17:42:47 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280336867</guid>
		<description><![CDATA[The U.S. Medicare program has listed its final plan for tightening payments for kidney dialysis treatment and proposed a new rule linking payment for services to performance standards. Reuters Health Information (Source: Medscape Business of Medicine Headlines)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target ="_self">MedMatcha, MedWorm's medical advertising network</a></b>, and receive $5 free advertising.</p></div> ]]></description>
			<content:encoded><![CDATA[<p>The U.S. Medicare program has listed its final plan for tightening payments for kidney dialysis treatment and proposed a new rule linking payment for services to performance standards. Reuters Health Information (Source: Medscape Business of Medicine Headlines)
<div id="medworm">
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target ="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/us-medicare-issues-final-dialysis-payment-rule/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Gates Lays Out Approach to Reducing Financial Impact of AIDS Epidemic</title>
		<link>http://medsnetic.com/blog/2010/07/28/gates-lays-out-approach-to-reducing-financial-impact-of-aids-epidemic/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/gates-lays-out-approach-to-reducing-financial-impact-of-aids-epidemic/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 15:08:26 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280328266</guid>
		<description><![CDATA[Bill Gates presented a plan to reduce the AIDS epidemic with more prevention, reduction of treatment costs, improved delivery of care, and more-efficient approaches to vaccine trials. Medscape Medical News (Source: Medscape Today Headlines) ]]></description>
			<content:encoded><![CDATA[<p>Bill Gates presented a plan to reduce the AIDS epidemic with more prevention, reduction of treatment costs, improved delivery of care, and more-efficient approaches to vaccine trials. Medscape Medical News (Source: Medscape Today Headlines) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/gates-lays-out-approach-to-reducing-financial-impact-of-aids-epidemic/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Investigator-initiated trials of targeted oncology agents: why independent research is at risk?</title>
		<link>http://medsnetic.com/blog/2010/07/28/investigator-initiated-trials-of-targeted-oncology-agents-why-independent-research-is-at-risk/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/investigator-initiated-trials-of-targeted-oncology-agents-why-independent-research-is-at-risk/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 14:43:51 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280324811</guid>
		<description><![CDATA[Conclusions: Investigator-initiated trials have led to the discovery and development of innovative, safe, and effective cancer treatments. To ensure that such research continues, action will be required on the parts of legislative and regulatory bodies, industry, universities, patient advocacy organisations, and preclinical and clinical academic scientists. (Source: Annals of Oncology) ]]></description>
			<content:encoded><![CDATA[<p>Conclusions: Investigator-initiated trials have led to the discovery and development of innovative, safe, and effective cancer treatments. To ensure that such research continues, action will be required on the parts of legislative and regulatory bodies, industry, universities, patient advocacy organisations, and preclinical and clinical academic scientists. (Source: Annals of Oncology) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/investigator-initiated-trials-of-targeted-oncology-agents-why-independent-research-is-at-risk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Habituating individuality: the framing of tuberculosis and its material solutions in republican china.</title>
		<link>http://medsnetic.com/blog/2010/07/28/habituating-individuality-the-framing-of-tuberculosis-and-its-material-solutions-in-republican-china/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/habituating-individuality-the-framing-of-tuberculosis-and-its-material-solutions-in-republican-china/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 14:33:03 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280325963</guid>
		<description><![CDATA[Authors: Lei SH In their endeavor to solve China's tuberculosis crisis, public health advocates in the 1930s framed tuberculosis as a disease of the Chinese family. Instead of being considered as a social disease, tuberculosis drew people's attention to the graphic details of personal health habits and the allegedly pathogenic structure of the Chinese family. Focusing on so-called unhygienic habits and on the selective acceptance, abandonment, or innovation of household utensils (such as the traditional sleeping platform, the individual cup, and the hygienic table), the author traces the process by which tuberculosis contributed to the making of the modern Chinese body by way of habituating individuality. PMID: 20657056 [PubMed - in process] (Source: Bulletin of the History of Medi... ]]></description>
			<content:encoded><![CDATA[<p>Authors: Lei SH In their endeavor to solve China&#8217;s tuberculosis crisis, public health advocates in the 1930s framed tuberculosis as a disease of the Chinese family. Instead of being considered as a social disease, tuberculosis drew people&#8217;s attention to the graphic details of personal health habits and the allegedly pathogenic structure of the Chinese family. Focusing on so-called unhygienic habits and on the selective acceptance, abandonment, or innovation of household utensils (such as the traditional sleeping platform, the individual cup, and the hygienic table), the author traces the process by which tuberculosis contributed to the making of the modern Chinese body by way of habituating individuality. PMID: 20657056 [PubMed - in process] (Source: Bulletin of the History of Medi&#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/habituating-individuality-the-framing-of-tuberculosis-and-its-material-solutions-in-republican-china/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Welshimer proposes plan to manage jail population</title>
		<link>http://medsnetic.com/blog/2010/07/28/welshimer-proposes-plan-to-manage-jail-population/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/welshimer-proposes-plan-to-manage-jail-population/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 14:08:09 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280324349</guid>
		<description><![CDATA[The Sedgwick County Commission on Wednesday discussed a proposal by Commissioner Gwen Welshimer that she says would help control the countyÃ¢ÂÂs jail population while avoiding a property tax increase. Commissioners voted to refer the plan to the Community Justice Coordinating Council for further review. (Source: bizjournals.com Health Care:Health Insurance headlines) ]]></description>
			<content:encoded><![CDATA[<p>The Sedgwick County Commission on Wednesday discussed a proposal by Commissioner Gwen Welshimer that she says would help control the countyÃ¢ÂÂs jail population while avoiding a property tax increase. Commissioners voted to refer the plan to the Community Justice Coordinating Council for further review. (Source: bizjournals.com Health Care:Health Insurance headlines) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/welshimer-proposes-plan-to-manage-jail-population/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Predictive values of hCG clearance for risk of methotrexate resistance in low-risk gestational trophoblastic neoplasias</title>
		<link>http://medsnetic.com/blog/2010/07/28/predictive-values-of-hcg-clearance-for-risk-of-methotrexate-resistance-in-low-risk-gestational-trophoblastic-neoplasias/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/predictive-values-of-hcg-clearance-for-risk-of-methotrexate-resistance-in-low-risk-gestational-trophoblastic-neoplasias/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 13:56:52 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280324812</guid>
		<description><![CDATA[Conclusion: In the second largest cohort of low-risk GTN patients reported to date, choriocarcinoma pathology and CLhCG &#8804;0.37 l/day were major independent predictive factors for MTX resistance risk. (Source: Annals of Oncology) ]]></description>
			<content:encoded><![CDATA[<p>Conclusion: In the second largest cohort of low-risk GTN patients reported to date, choriocarcinoma pathology and CLhCG &le;0.37 l/day were major independent predictive factors for MTX resistance risk. (Source: Annals of Oncology) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/predictive-values-of-hcg-clearance-for-risk-of-methotrexate-resistance-in-low-risk-gestational-trophoblastic-neoplasias/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Grant will connect Los Angeles County clinics to HIE</title>
		<link>http://medsnetic.com/blog/2010/07/28/grant-will-connect-los-angeles-county-clinics-to-hie/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/grant-will-connect-los-angeles-county-clinics-to-hie/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 13:47:57 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280324397</guid>
		<description><![CDATA[L.A. Care Health Plan has approved $153,000 in funding for the Western Health Information Network (WHIN) to help connect a minimum of 10 Los Angeles County community clinics to an existing health information exchange network. (Source: Healthcare IT News) ]]></description>
			<content:encoded><![CDATA[<p>L.A. Care Health Plan has approved $153,000 in funding for the Western Health Information Network (WHIN) to help connect a minimum of 10 Los Angeles County community clinics to an existing health information exchange network. (Source: Healthcare IT News) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/grant-will-connect-los-angeles-county-clinics-to-hie/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>National Briefing &#124; West: California: Oakland Votes to Allow Large-Scale Marijuana Farming</title>
		<link>http://medsnetic.com/blog/2010/07/28/national-briefing-west-california-oakland-votes-to-allow-large-scale-marijuana-farming-2/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/national-briefing-west-california-oakland-votes-to-allow-large-scale-marijuana-farming-2/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 13:26:04 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280321404</guid>
		<description><![CDATA[The Oakland City Council voted in favor of a plan to license four factories where marijuana would be grown and packaged for medical use. (Source: NYT) ]]></description>
			<content:encoded><![CDATA[<p>The Oakland City Council voted in favor of a plan to license four factories where marijuana would be grown and packaged for medical use. (Source: NYT) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/national-briefing-west-california-oakland-votes-to-allow-large-scale-marijuana-farming-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>California&#8217;s Anthem Blue Cross Names New President</title>
		<link>http://medsnetic.com/blog/2010/07/28/californias-anthem-blue-cross-names-new-president/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/californias-anthem-blue-cross-names-new-president/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 11:45:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280314800</guid>
		<description><![CDATA[Anthem Blue Cross of California has named former Aetna executive Pam Kehaly to head the insurer after its president resigned a week ago, Los Angeles Times reports. "Kehaly will take the helm Aug. 30. Anthem, a unit of Indianapolis-based WellPoint Inc., is California's largest for-profit health insurance company." Anthem came under intense scrutiny earlier this year over a planned rate hike of up to 39 percent for many of its individual insurance plan holders... (Source: Health News from Medical News Today) ]]></description>
			<content:encoded><![CDATA[<p>Anthem Blue Cross of California has named former Aetna executive Pam Kehaly to head the insurer after its president resigned a week ago, Los Angeles Times reports. &#8220;Kehaly will take the helm Aug. 30. Anthem, a unit of Indianapolis-based WellPoint Inc., is California&#8217;s largest for-profit health insurance company.&#8221; Anthem came under intense scrutiny earlier this year over a planned rate hike of up to 39 percent for many of its individual insurance plan holders&#8230; (Source: Health News from Medical News Today) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/californias-anthem-blue-cross-names-new-president/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Alcohol and arthritis link examined</title>
		<link>http://medsnetic.com/blog/2010/07/28/alcohol-and-arthritis-link-examined/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/alcohol-and-arthritis-link-examined/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 09:54:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280309940</guid>
		<description><![CDATA[Conclusion
This study appears to show an association between a higher frequency of alcohol consumption and both reduced risk of developing rheumatoid arthritis and decreased severity of the disease. However, there are limitations to this study (many of which the researchers highlight), which mean that the conclusions should be interpreted cautiously: This study required the patients to recall their own alcohol consumption, meaning the patients and controls may have over- or under-estimated the amount of alcohol they had consumed. The study asked the participants about the frequency of their drinking rather than about how much they typically drank. As we cannot tell what quantities of alcohol were consumed, it is therefore possible that some individuals who drank less frequently might... ]]></description>
			<content:encoded><![CDATA[<p>Conclusion<br />
This study appears to show an association between a higher frequency of alcohol consumption and both reduced risk of developing rheumatoid arthritis and decreased severity of the disease. However, there are limitations to this study (many of which the researchers highlight), which mean that the conclusions should be interpreted cautiously: This study required the patients to recall their own alcohol consumption, meaning the patients and controls may have over- or under-estimated the amount of alcohol they had consumed. The study asked the participants about the frequency of their drinking rather than about how much they typically drank. As we cannot tell what quantities of alcohol were consumed, it is therefore possible that some individuals who drank less frequently might&#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/alcohol-and-arthritis-link-examined/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Which antiplatelet therapy is best for patients on PPIs? New trial to the rescue</title>
		<link>http://medsnetic.com/blog/2010/07/28/which-antiplatelet-therapy-is-best-for-patients-on-ppis-new-trial-to-the-rescue/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/which-antiplatelet-therapy-is-best-for-patients-on-ppis-new-trial-to-the-rescue/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 09:37:04 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280306284</guid>
		<description><![CDATA[A Paris-based clinical trial will set out to determine the efficacy of two antiplatelet drugs, prasugrel (Effient, Daiichi-Sankyo/Eli Lilly) or a double dose of clopidogrel (Plavix, Bristol-Myers Squibb/Sanofi Aventis), in coronary artery disease patients who are taking lansoprazole (Prevacid, Takeda), a proton-pump inhibitor. (Source: Cardiovascular Business News) ]]></description>
			<content:encoded><![CDATA[<p>A Paris-based clinical trial will set out to determine the efficacy of two antiplatelet drugs, prasugrel (Effient, Daiichi-Sankyo/Eli Lilly) or a double dose of clopidogrel (Plavix, Bristol-Myers Squibb/Sanofi Aventis), in coronary artery disease patients who are taking lansoprazole (Prevacid, Takeda), a proton-pump inhibitor. (Source: Cardiovascular Business News) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/which-antiplatelet-therapy-is-best-for-patients-on-ppis-new-trial-to-the-rescue/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DIATHERIX Laboratories Launches STD And HSV Test Panel</title>
		<link>http://medsnetic.com/blog/2010/07/28/diatherix-laboratories-launches-std-and-hsv-test-panel/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/diatherix-laboratories-launches-std-and-hsv-test-panel/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 08:18:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280304000</guid>
		<description><![CDATA[DIATHERIX Laboratories, adds a Sexually Transmitted Disease (STD) panel and Herpes Simplex Virus (HSV) panel to its line up of highly sensitive, rapid response diagnostic panels. The HSV panel identifies herpes simplex viruses 1 and 2 and the STD panel identifies 10 sexually transmitted diseases simultaneously, many of which cannot be accurately identified by current testing methods. These STD organisms, if not appropriately treated, can cause diseases such as syphilis, gonorrhoeae, chlamydia, bacterial vaginosis, etc. and may lead to blindness, infertility or complications during pregnancy... (Source: Health News from Medical News Today) ]]></description>
			<content:encoded><![CDATA[<p>DIATHERIX Laboratories, adds a Sexually Transmitted Disease (STD) panel and Herpes Simplex Virus (HSV) panel to its line up of highly sensitive, rapid response diagnostic panels. The HSV panel identifies herpes simplex viruses 1 and 2 and the STD panel identifies 10 sexually transmitted diseases simultaneously, many of which cannot be accurately identified by current testing methods. These STD organisms, if not appropriately treated, can cause diseases such as syphilis, gonorrhoeae, chlamydia, bacterial vaginosis, etc. and may lead to blindness, infertility or complications during pregnancy&#8230; (Source: Health News from Medical News Today) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/diatherix-laboratories-launches-std-and-hsv-test-panel/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>High capacity and excellent cycling stability of branched cobalt oxide nanowires as Li-insertion materials</title>
		<link>http://medsnetic.com/blog/2010/07/28/high-capacity-and-excellent-cycling-stability-of-branched-cobalt-oxide-nanowires-as-li-insertion-materials/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/high-capacity-and-excellent-cycling-stability-of-branched-cobalt-oxide-nanowires-as-li-insertion-materials/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 07:04:25 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280299525</guid>
		<description><![CDATA[Cheng Chao Li, Xiao Ming Yin, Li Bao Chen, Qiu Hong Li, and Tai Hong Wang In this paper, the authors report the high-performance lithium storage properties of branched cobalt oxide nanowires synthesized through a topotactic conversion route. Compared with other nanosized materials, such branched nanostructures not only inherit the advantages of high surface-to-volume rati ... [Appl. Phys. Lett. 97, 043501 (2010)] published Tue Jul 27, 2010. (Source: Applied Physics Letters) ]]></description>
			<content:encoded><![CDATA[<p>Cheng Chao Li, Xiao Ming Yin, Li Bao Chen, Qiu Hong Li, and Tai Hong Wang In this paper, the authors report the high-performance lithium storage properties of branched cobalt oxide nanowires synthesized through a topotactic conversion route. Compared with other nanosized materials, such branched nanostructures not only inherit the advantages of high surface-to-volume rati &#8230; [Appl. Phys. Lett. 97, 043501 (2010)] published Tue Jul 27, 2010. (Source: Applied Physics Letters) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/high-capacity-and-excellent-cycling-stability-of-branched-cobalt-oxide-nanowires-as-li-insertion-materials/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Extended Daylight Hours Influence Teens&#8217; Sleeping Patterns</title>
		<link>http://medsnetic.com/blog/2010/07/28/extended-daylight-hours-influence-teens-sleeping-patterns/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/extended-daylight-hours-influence-teens-sleeping-patterns/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 06:53:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280296800</guid>
		<description><![CDATA[In the spring, later sunset and extended daylight exposure delay bedtimes in teenagers, according to researchers at Rensselaer Polytechnic Institute's Lighting Research Center (LRC). "Biologically, this increased exposure to early evening light in the spring delays the onset of nocturnal melatonin, a hormone that indicates to the body when it's nighttime," explains Mariana Figueiro, Ph.D., associate professor. "This extended exposure adds to the difficulties teens have falling asleep at a reasonable hour... (Source: Health News from Medical News Today) ]]></description>
			<content:encoded><![CDATA[<p>In the spring, later sunset and extended daylight exposure delay bedtimes in teenagers, according to researchers at Rensselaer Polytechnic Institute&#8217;s Lighting Research Center (LRC). &#8220;Biologically, this increased exposure to early evening light in the spring delays the onset of nocturnal melatonin, a hormone that indicates to the body when it&#8217;s nighttime,&#8221; explains Mariana Figueiro, Ph.D., associate professor. &#8220;This extended exposure adds to the difficulties teens have falling asleep at a reasonable hour&#8230; (Source: Health News from Medical News Today) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/extended-daylight-hours-influence-teens-sleeping-patterns/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cutaneous Sarcoidosis</title>
		<link>http://medsnetic.com/blog/2010/07/28/cutaneous-sarcoidosis-2/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/cutaneous-sarcoidosis-2/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 06:42:19 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280296459</guid>
		<description><![CDATA[Semin Respir Crit Care Med 2010; 31: 442-451DOI: 10.1055/s-0030-1262212ABSTRACTSarcoidosis is a systemic disease with skin manifestations. Skin manifestations are classified as nonspecific if they are not characterized by granulomatous inflammation and specific if the lesions have granulomas histologically. Erythema nodosum is the most common nonspecific skin manifestation, and it portends a good prognosis. Specific skin lesions have a varied clinical appearance, although often they can be distinguished by their yellow translucent character. Despite the potential variable appearance, there are common clinical presentations. Lupus pernio lesions are nodular violaceous specific skin lesions found predominantly on the face associated with scarring and a poor prognosis. Treatment of cutaneous ... ]]></description>
			<content:encoded><![CDATA[<p>Semin Respir Crit Care Med 2010; 31: 442-451DOI: 10.1055/s-0030-1262212ABSTRACTSarcoidosis is a systemic disease with skin manifestations. Skin manifestations are classified as nonspecific if they are not characterized by granulomatous inflammation and specific if the lesions have granulomas histologically. Erythema nodosum is the most common nonspecific skin manifestation, and it portends a good prognosis. Specific skin lesions have a varied clinical appearance, although often they can be distinguished by their yellow translucent character. Despite the potential variable appearance, there are common clinical presentations. Lupus pernio lesions are nodular violaceous specific skin lesions found predominantly on the face associated with scarring and a poor prognosis. Treatment of cutaneous &#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/cutaneous-sarcoidosis-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>African Leaders Agree on Ways Forward on Maternal and Child Health &#8211; 27 July 2010</title>
		<link>http://medsnetic.com/blog/2010/07/28/african-leaders-agree-on-ways-forward-on-maternal-and-child-health-27-july-2010/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/african-leaders-agree-on-ways-forward-on-maternal-and-child-health-27-july-2010/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 06:42:14 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280297114</guid>
		<description><![CDATA[KAMPALA, Uganda &#8212; The high-level debate which opened in Kampala, Uganda, yesterday on &#8220;Promoting Maternal, Infant and Child Health and Development in Africa, ended this evening with an agreement by Africa&#8217;s leaders on an action plan to kick-start the effective implementation of existing resolutions and decisions on maternal, infant and child health in the continent. (Source: UNFPA News) ]]></description>
			<content:encoded><![CDATA[<p>KAMPALA, Uganda &mdash; The high-level debate which opened in Kampala, Uganda, yesterday on &ldquo;Promoting Maternal, Infant and Child Health and Development in Africa, ended this evening with an agreement by Africa&rsquo;s leaders on an action plan to kick-start the effective implementation of existing resolutions and decisions on maternal, infant and child health in the continent. (Source: UNFPA News) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/african-leaders-agree-on-ways-forward-on-maternal-and-child-health-27-july-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cutaneous Sarcoidosis</title>
		<link>http://medsnetic.com/blog/2010/07/28/cutaneous-sarcoidosis/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/cutaneous-sarcoidosis/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 06:21:19 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280296459</guid>
		<description><![CDATA[Semin Respir Crit Care Med 2010; 31: 442-451DOI: 10.1055/s-0030-1262212ABSTRACTSarcoidosis is a systemic disease with skin manifestations. Skin manifestations are classified as nonspecific if they are not characterized by granulomatous inflammation and specific if the lesions have granulomas histologically. Erythema nodosum is the most common nonspecific skin manifestation, and it portends a good prognosis. Specific skin lesions have a varied clinical appearance, although often they can be distinguished by their yellow translucent character. Despite the potential variable appearance, there are common clinical presentations. Lupus pernio lesions are nodular violaceous specific skin lesions found predominantly on the face associated with scarring and a poor prognosis. Treatment of cutaneous ... ]]></description>
			<content:encoded><![CDATA[<p>Semin Respir Crit Care Med 2010; 31: 442-451DOI: 10.1055/s-0030-1262212ABSTRACTSarcoidosis is a systemic disease with skin manifestations. Skin manifestations are classified as nonspecific if they are not characterized by granulomatous inflammation and specific if the lesions have granulomas histologically. Erythema nodosum is the most common nonspecific skin manifestation, and it portends a good prognosis. Specific skin lesions have a varied clinical appearance, although often they can be distinguished by their yellow translucent character. Despite the potential variable appearance, there are common clinical presentations. Lupus pernio lesions are nodular violaceous specific skin lesions found predominantly on the face associated with scarring and a poor prognosis. Treatment of cutaneous &#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/cutaneous-sarcoidosis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Extended Daylight Hours Influence Teens&#8217; Sleeping Patterns</title>
		<link>http://medsnetic.com/blog/2010/07/28/extended-daylight-hours-influence-teens-sleeping-patterns-2/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/extended-daylight-hours-influence-teens-sleeping-patterns-2/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 06:19:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280296800</guid>
		<description><![CDATA[In the spring, later sunset and extended daylight exposure delay bedtimes in teenagers, according to researchers at Rensselaer Polytechnic Institute's Lighting Research Center (LRC). "Biologically, this increased exposure to early evening light in the spring delays the onset of nocturnal melatonin, a hormone that indicates to the body when it's nighttime," explains Mariana Figueiro, Ph.D., associate professor. "This extended exposure adds to the difficulties teens have falling asleep at a reasonable hour... (Source: Health News from Medical News Today) ]]></description>
			<content:encoded><![CDATA[<p>In the spring, later sunset and extended daylight exposure delay bedtimes in teenagers, according to researchers at Rensselaer Polytechnic Institute&#8217;s Lighting Research Center (LRC). &#8220;Biologically, this increased exposure to early evening light in the spring delays the onset of nocturnal melatonin, a hormone that indicates to the body when it&#8217;s nighttime,&#8221; explains Mariana Figueiro, Ph.D., associate professor. &#8220;This extended exposure adds to the difficulties teens have falling asleep at a reasonable hour&#8230; (Source: Health News from Medical News Today) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/extended-daylight-hours-influence-teens-sleeping-patterns-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Reply</title>
		<link>http://medsnetic.com/blog/2010/07/28/reply/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/reply/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 05:52:32 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280294552</guid>
		<description><![CDATA[We appreciate the interest and comments about our article. Drs Tariq and Mitchell state that some literature on Stratus OCT report retinal thinning in diabetics with minimal or no diabetic retinopathy (DR)Ã¢ÂÂin contrast to our article, which reported no thinning compared with controls. Drs Tariq and Mitchell also ask whether such discrepancy between studies may be accounted for by correcting for the effects of race, age, and sex on retinal thickness (as we did in our study). This is an excellent point and, in our opinion, a very important consideration when designing or interpreting studies with OCT-based outcomes. (Source: American Journal of Ophthalmology) ]]></description>
			<content:encoded><![CDATA[<p>We appreciate the interest and comments about our article. Drs Tariq and Mitchell state that some literature on Stratus OCT report retinal thinning in diabetics with minimal or no diabetic retinopathy (DR)Ã¢ÂÂin contrast to our article, which reported no thinning compared with controls. Drs Tariq and Mitchell also ask whether such discrepancy between studies may be accounted for by correcting for the effects of race, age, and sex on retinal thickness (as we did in our study). This is an excellent point and, in our opinion, a very important consideration when designing or interpreting studies with OCT-based outcomes. (Source: American Journal of Ophthalmology) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/reply/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Depression and Incident Diabetic Foot Ulcers: A Prospective Cohort Study</title>
		<link>http://medsnetic.com/blog/2010/07/28/depression-and-incident-diabetic-foot-ulcers-a-prospective-cohort-study/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/depression-and-incident-diabetic-foot-ulcers-a-prospective-cohort-study/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 05:51:39 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280293119</guid>
		<description><![CDATA[Conclusion: Major depression by Patient Health Questionnaire-9 is associated with a 2-fold higher risk of incident diabetic foot ulcers. Future studies of this association should include better measures of peripheral neuropathy and peripheral arterial disease, which are possible confounders or mediators. (Source: The American Journal of Medicine) ]]></description>
			<content:encoded><![CDATA[<p>Conclusion: Major depression by Patient Health Questionnaire-9 is associated with a 2-fold higher risk of incident diabetic foot ulcers. Future studies of this association should include better measures of peripheral neuropathy and peripheral arterial disease, which are possible confounders or mediators. (Source: The American Journal of Medicine) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/depression-and-incident-diabetic-foot-ulcers-a-prospective-cohort-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Macular Thickness in Diabetic Subjects Without Retinopathy</title>
		<link>http://medsnetic.com/blog/2010/07/28/macular-thickness-in-diabetic-subjects-without-retinopathy/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/macular-thickness-in-diabetic-subjects-without-retinopathy/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 05:41:31 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280294551</guid>
		<description><![CDATA[The recent report by Kashani and associates analyzing retinal thickness by race, gender, and age adds to the growing literature on optical coherence tomography measured retinal parameters in different populations. Kashani and associates reported Stratus OCT measurements of macular parameters in white, black, and Hispanic individuals of both sexes, including those with diabetes but without retinopathy. They reported no significant differences in the macular parameters of individuals with diabetes without retinopathy compared with controls, using data adjusted for race, gender, and age group. They also reported that mean foveal thickness and foveal center point thickness were statistically greater in males than in females. Black persons had a significantly thinner mean foveal thickness and c... ]]></description>
			<content:encoded><![CDATA[<p>The recent report by Kashani and associates analyzing retinal thickness by race, gender, and age adds to the growing literature on optical coherence tomography measured retinal parameters in different populations. Kashani and associates reported Stratus OCT measurements of macular parameters in white, black, and Hispanic individuals of both sexes, including those with diabetes but without retinopathy. They reported no significant differences in the macular parameters of individuals with diabetes without retinopathy compared with controls, using data adjusted for race, gender, and age group. They also reported that mean foveal thickness and foveal center point thickness were statistically greater in males than in females. Black persons had a significantly thinner mean foveal thickness and c&#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/macular-thickness-in-diabetic-subjects-without-retinopathy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Indomethacin Activates Peroxisome Proliferator-activated Receptor ÃÂ³ to Improve Insulin Resistance in Cotton Pellet Granuloma Model</title>
		<link>http://medsnetic.com/blog/2010/07/28/indomethacin-activates-peroxisome-proliferator-activated-receptor-a%c2%8ea%c2%b3-to-improve-insulin-resistance-in-cotton-pellet-granuloma-model/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/indomethacin-activates-peroxisome-proliferator-activated-receptor-a%c2%8ea%c2%b3-to-improve-insulin-resistance-in-cotton-pellet-granuloma-model/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 05:35:06 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280291886</guid>
		<description><![CDATA[Horm Metab ResDOI: 10.1055/s-0030-1261952AbstractInflammation is involved in the development of insulin resistance and diabetes. However, the effectiveness of anti-inflammatory drugs in diabetic therapy remains obscure. In the present study, the possible mechanisms of indomethacin, one of the nonsteroidal anti-inflammatory drugs, in the improvement of insulin resistance were investigated. Indomethacin treatment significantly decreased cotton pellet implantation induced white blood cell count elevation and immune cells infiltration in epididymal white adipose tissue. Also, cotton pellet implantation induced impaired glucose utilization and insulin resistance were improved by indomethacin. The decrement in phosphoinsulin receptor and phospho-Akt levels induced by cotton pellet implantation w... ]]></description>
			<content:encoded><![CDATA[<p>Horm Metab ResDOI: 10.1055/s-0030-1261952AbstractInflammation is involved in the development of insulin resistance and diabetes. However, the effectiveness of anti-inflammatory drugs in diabetic therapy remains obscure. In the present study, the possible mechanisms of indomethacin, one of the nonsteroidal anti-inflammatory drugs, in the improvement of insulin resistance were investigated. Indomethacin treatment significantly decreased cotton pellet implantation induced white blood cell count elevation and immune cells infiltration in epididymal white adipose tissue. Also, cotton pellet implantation induced impaired glucose utilization and insulin resistance were improved by indomethacin. The decrement in phosphoinsulin receptor and phospho-Akt levels induced by cotton pellet implantation w&#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/indomethacin-activates-peroxisome-proliferator-activated-receptor-a%c2%8ea%c2%b3-to-improve-insulin-resistance-in-cotton-pellet-granuloma-model/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cytomegalovirus Infection: A Potential Threat to Atrioventricular Conduction?</title>
		<link>http://medsnetic.com/blog/2010/07/28/cytomegalovirus-infection-a-potential-threat-to-atrioventricular-conduction/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/cytomegalovirus-infection-a-potential-threat-to-atrioventricular-conduction/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 05:22:40 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280293120</guid>
		<description><![CDATA[In January 2009, a 34-year-old woman with transient high-degree atrioventricular block was referred to the Hippokration Hospital (A). The patient reported effort dyspnea accompanied by asthenia, headaches, myalgias, and diffuse arthralgias, but not syncope. Her medical history was unremarkable, and she did not report smoking, alcohol, or illicit drug abuse and never received blood products. There was no family history of rhythm and conduction disorders. (Source: The American Journal of Medicine) ]]></description>
			<content:encoded><![CDATA[<p>In January 2009, a 34-year-old woman with transient high-degree atrioventricular block was referred to the Hippokration Hospital (A). The patient reported effort dyspnea accompanied by asthenia, headaches, myalgias, and diffuse arthralgias, but not syncope. Her medical history was unremarkable, and she did not report smoking, alcohol, or illicit drug abuse and never received blood products. There was no family history of rhythm and conduction disorders. (Source: The American Journal of Medicine) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/cytomegalovirus-infection-a-potential-threat-to-atrioventricular-conduction/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Office of the Assistant Secretary for Planning and Evaluation; Request for Comments on the Departmental FY 2010-2015 Strategic Plan</title>
		<link>http://medsnetic.com/blog/2010/07/28/office-of-the-assistant-secretary-for-planning-and-evaluation-request-for-comments-on-the-departmental-fy-2010-2015-strategic-plan/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/office-of-the-assistant-secretary-for-planning-and-evaluation-request-for-comments-on-the-departmental-fy-2010-2015-strategic-plan/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 05:15:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280293200</guid>
		<description><![CDATA[The Department of Health and Human Services (HHS) is seeking public comment on its draft Strategic Plan for fiscal years 2010-2015. (Source: Federal Register updates via the Rural Assistance Center) ]]></description>
			<content:encoded><![CDATA[<p>The Department of Health and Human Services (HHS) is seeking public comment on its draft Strategic Plan for fiscal years 2010-2015. (Source: Federal Register updates via the Rural Assistance Center) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/office-of-the-assistant-secretary-for-planning-and-evaluation-request-for-comments-on-the-departmental-fy-2010-2015-strategic-plan/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prevalence and Characteristics of Tinnitus among US Adults</title>
		<link>http://medsnetic.com/blog/2010/07/28/prevalence-and-characteristics-of-tinnitus-among-us-adults/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/prevalence-and-characteristics-of-tinnitus-among-us-adults/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 05:10:38 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280293118</guid>
		<description><![CDATA[Conclusions: The prevalence of frequent tinnitus is highest among older adults, non-Hispanic whites, former smokers, and adults with hypertension, hearing impairment, loud noise exposure, or generalized anxiety disorder. Prospective studies of risk factors for tinnitus are needed. (Source: The American Journal of Medicine) ]]></description>
			<content:encoded><![CDATA[<p>Conclusions: The prevalence of frequent tinnitus is highest among older adults, non-Hispanic whites, former smokers, and adults with hypertension, hearing impairment, loud noise exposure, or generalized anxiety disorder. Prospective studies of risk factors for tinnitus are needed. (Source: The American Journal of Medicine) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/prevalence-and-characteristics-of-tinnitus-among-us-adults/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>LISINOPRIL WITH HYDROCHLOROTHIAZIDE (Lisinopril And Hydrochlorothiazide) Tablet [West-Ward Pharmaceutical Corp]</title>
		<link>http://medsnetic.com/blog/2010/07/28/lisinopril-with-hydrochlorothiazide-lisinopril-and-hydrochlorothiazide-tablet-west-ward-pharmaceutical-corp/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/lisinopril-with-hydrochlorothiazide-lisinopril-and-hydrochlorothiazide-tablet-west-ward-pharmaceutical-corp/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 04:53:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280289600</guid>
		<description><![CDATA[Updated Date: Jul 28, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)) ]]></description>
			<content:encoded><![CDATA[<p>Updated Date: Jul 28, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/lisinopril-with-hydrochlorothiazide-lisinopril-and-hydrochlorothiazide-tablet-west-ward-pharmaceutical-corp/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Technological Innovations in Surgical Approach for Thyroid Cancer</title>
		<link>http://medsnetic.com/blog/2010/07/28/technological-innovations-in-surgical-approach-for-thyroid-cancer/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/technological-innovations-in-surgical-approach-for-thyroid-cancer/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 04:48:11 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280290451</guid>
		<description><![CDATA[Over the last decade, surgeons have witnessed dramatic changes in surgical practice as a result of the introduction of new technological advancement. Some of these changes include refinement of techniques in thyroid cancer surgery. The development of various endoscopic thyroidectomy techniques, the addition of the da Vinci robot, and the use of operative adjuncts in thyroid surgery, such as intraoperative neuromonitoring and quick intraoperative parathyroid hormone, have made thyroid cancer surgery not only safer and better accepted by patients with thyroid cancer but also offer them more surgical treatment options. (Source: Journal of Oncology) ]]></description>
			<content:encoded><![CDATA[<p>Over the last decade, surgeons have witnessed dramatic changes in surgical practice as a result of the introduction of new technological advancement. Some of these changes include refinement of techniques in thyroid cancer surgery. The development of various endoscopic thyroidectomy techniques, the addition of the da Vinci robot, and the use of operative adjuncts in thyroid surgery, such as intraoperative neuromonitoring and quick intraoperative parathyroid hormone, have made thyroid cancer surgery not only safer and better accepted by patients with thyroid cancer but also offer them more surgical treatment options. (Source: Journal of Oncology) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/technological-innovations-in-surgical-approach-for-thyroid-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Director&#8217;s Comments: HHS&#8217; Health Literacy National Action Plan</title>
		<link>http://medsnetic.com/blog/2010/07/28/directors-comments-hhs-health-literacy-national-action-plan/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/directors-comments-hhs-health-literacy-national-action-plan/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 04:42:41 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280290421</guid>
		<description><![CDATA[Listen to the NLM Director's Comments on HHS' Health Literacy National Action Plan. The transcript is also available. The U.S. Department of Health and Human Services (HHS) recently announced a national action plan to enhance the country's health literacy... (Source: What's New on MedlinePlus)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target ="_self">MedMatcha, MedWorm's medical advertising network</a></b>, and receive $5 free advertising.</p></div> ]]></description>
			<content:encoded><![CDATA[<p>Listen to the NLM Director&#8217;s Comments on HHS&#8217; Health Literacy National Action Plan. The transcript is also available. The U.S. Department of Health and Human Services (HHS) recently announced a national action plan to enhance the country&#8217;s health literacy&#8230; (Source: What&#8217;s New on MedlinePlus)
<div id="medworm">
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target ="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/directors-comments-hhs-health-literacy-national-action-plan/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>National Briefing &#124; West: California: Oakland Votes to Allow Large-Scale Marijuana Farming</title>
		<link>http://medsnetic.com/blog/2010/07/28/national-briefing-west-california-oakland-votes-to-allow-large-scale-marijuana-farming/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/national-briefing-west-california-oakland-votes-to-allow-large-scale-marijuana-farming/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 03:53:51 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280287191</guid>
		<description><![CDATA[The Oakland City Council voted in favor of a plan to license four factories where marijuana would be grown and packaged for medical use. (Source: NYT Health) ]]></description>
			<content:encoded><![CDATA[<p>The Oakland City Council voted in favor of a plan to license four factories where marijuana would be grown and packaged for medical use. (Source: NYT Health) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/national-briefing-west-california-oakland-votes-to-allow-large-scale-marijuana-farming/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Spring light influences teen sleep</title>
		<link>http://medsnetic.com/blog/2010/07/28/spring-light-influences-teen-sleep/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/spring-light-influences-teen-sleep/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 03:43:20 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280285960</guid>
		<description><![CDATA[TROY, N.Y., July 27 (UPI) -- Long daylight hours in spring influence the sleeping patterns of teens, researchers at Rensselaer Polytechnic Institute in Troy, N.Y., said. Rensselaer Polytechnic Institute - Troy New York - New York - United States - Troy (Source: Health News - UPI.com) ]]></description>
			<content:encoded><![CDATA[<p>TROY, N.Y., July 27 (UPI) &#8212; Long daylight hours in spring influence the sleeping patterns of teens, researchers at Rensselaer Polytechnic Institute in Troy, N.Y., said. Rensselaer Polytechnic Institute &#8211; Troy New York &#8211; New York &#8211; United States &#8211; Troy (Source: Health News &#8211; UPI.com) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/spring-light-influences-teen-sleep/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Middle school students co-author research on enzyme for activating promising disease-fighters</title>
		<link>http://medsnetic.com/blog/2010/07/28/middle-school-students-co-author-research-on-enzyme-for-activating-promising-disease-fighters-2/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/middle-school-students-co-author-research-on-enzyme-for-activating-promising-disease-fighters-2/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 03:27:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280286000</guid>
		<description><![CDATA[(American Chemical Society) Grown-ups aren't the only ones making exciting scientific discoveries these days. Two middle school students from Wisconsin joined a team of scientists who are reporting the first glimpse of the innermost structure of a key bacterial enzyme. It helps activate certain antibiotics and anti-cancer agents so that those substances do their job. Their study appears in ACS' weekly journal Biochemistry. (Source: EurekAlert! - Medicine and Health) ]]></description>
			<content:encoded><![CDATA[<p>(American Chemical Society) Grown-ups aren&#8217;t the only ones making exciting scientific discoveries these days. Two middle school students from Wisconsin joined a team of scientists who are reporting the first glimpse of the innermost structure of a key bacterial enzyme. It helps activate certain antibiotics and anti-cancer agents so that those substances do their job. Their study appears in ACS&#8217; weekly journal Biochemistry. (Source: EurekAlert! &#8211; Medicine and Health) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/middle-school-students-co-author-research-on-enzyme-for-activating-promising-disease-fighters-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Panel to Vote on Blood Thinner Ticagrelor</title>
		<link>http://medsnetic.com/blog/2010/07/28/fda-panel-to-vote-on-blood-thinner-ticagrelor/</link>
		<comments>http://medsnetic.com/blog/2010/07/28/fda-panel-to-vote-on-blood-thinner-ticagrelor/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 02:59:14 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280283194</guid>
		<description><![CDATA[WASHINGTON (MedPage Today) -- FDA reviewers said AstraZeneca's investigational antiplatelet ticagrelor (Brilinta) appears more effective than clopidogrel (Plavix) for patients with acute coronary syndrome, but expressed concern that the findings didn't hold up in a U.S. population. (Source: MedPage Today Public Health) ]]></description>
			<content:encoded><![CDATA[<p>WASHINGTON (MedPage Today) &#8212; FDA reviewers said AstraZeneca&#8217;s investigational antiplatelet ticagrelor (Brilinta) appears more effective than clopidogrel (Plavix) for patients with acute coronary syndrome, but expressed concern that the findings didn&#8217;t hold up in a U.S. population. (Source: MedPage Today Public Health) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/28/fda-panel-to-vote-on-blood-thinner-ticagrelor/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Termination Can Get Results</title>
		<link>http://medsnetic.com/blog/2010/07/27/termination-can-get-results/</link>
		<comments>http://medsnetic.com/blog/2010/07/27/termination-can-get-results/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 23:39:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280271600</guid>
		<description><![CDATA[According to early results of the July TMA survey on health plan contracts, 29 percent of practices have terminated one or more contracts within the last two years. (Source: Blogged_Arteries) ]]></description>
			<content:encoded><![CDATA[<p>According to early results of the July TMA survey on health plan contracts, 29 percent of practices have terminated one or more contracts within the last two years. (Source: Blogged_Arteries) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/27/termination-can-get-results/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Antismoking Efforts Lose Ground to Obesity Fight</title>
		<link>http://medsnetic.com/blog/2010/07/27/antismoking-efforts-lose-ground-to-obesity-fight/</link>
		<comments>http://medsnetic.com/blog/2010/07/27/antismoking-efforts-lose-ground-to-obesity-fight/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 23:19:54 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280271894</guid>
		<description><![CDATA[As public health priorities shift, anti-tobacco programs are losing out to the campaign against obesity. (Source: NYT Health) ]]></description>
			<content:encoded><![CDATA[<p>As public health priorities shift, anti-tobacco programs are losing out to the campaign against obesity. (Source: NYT Health) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/27/antismoking-efforts-lose-ground-to-obesity-fight/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Effects of vigorous late-night exercise on sleep quality and cardiac autonomic activity</title>
		<link>http://medsnetic.com/blog/2010/07/27/effects-of-vigorous-late-night-exercise-on-sleep-quality-and-cardiac-autonomic-activity/</link>
		<comments>http://medsnetic.com/blog/2010/07/27/effects-of-vigorous-late-night-exercise-on-sleep-quality-and-cardiac-autonomic-activity/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 22:41:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280268000</guid>
		<description><![CDATA[Sleep is the most important period for recovery from daily load. Regular physical activity enhances overall sleep quality, but the effects of acute exercise on sleep are not well defined. In sleep hygiene recommendations, intensive exercising is not suggested within the last 3 h before bed time, but this recommendation has not been adequately tested experimentally. Therefore, the effects of vigorous late-night exercise on sleep were examined by measuring polysomnographic, actigraphic and subjective sleep quality, as well as cardiac autonomic activity. Eleven (seven men, four women) physically fit young adults (VO2max 54 ÃÂ± 8 mLÃÂ·kg[minus]1ÃÂ·min[minus]1, age 26 ÃÂ± 3 years) were monitored in a sleep laboratory twice in a counterbalanced order: (1) after vigorous late-night exercise; and (2) ... ]]></description>
			<content:encoded><![CDATA[<p>Sleep is the most important period for recovery from daily load. Regular physical activity enhances overall sleep quality, but the effects of acute exercise on sleep are not well defined. In sleep hygiene recommendations, intensive exercising is not suggested within the last 3 h before bed time, but this recommendation has not been adequately tested experimentally. Therefore, the effects of vigorous late-night exercise on sleep were examined by measuring polysomnographic, actigraphic and subjective sleep quality, as well as cardiac autonomic activity. Eleven (seven men, four women) physically fit young adults (VO2max 54 ÃÂ± 8 mLÃÂ·kg[minus]1ÃÂ·min[minus]1, age 26 ÃÂ± 3 years) were monitored in a sleep laboratory twice in a counterbalanced order: (1) after vigorous late-night exercise; and (2) &#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/27/effects-of-vigorous-late-night-exercise-on-sleep-quality-and-cardiac-autonomic-activity/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Recipe for Longevity: No Smoking, and Lots of Friends</title>
		<link>http://medsnetic.com/blog/2010/07/27/recipe-for-longevity-no-smoking-and-lots-of-friends/</link>
		<comments>http://medsnetic.com/blog/2010/07/27/recipe-for-longevity-no-smoking-and-lots-of-friends/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 22:33:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280267400</guid>
		<description><![CDATA[A large new meta-analysis suggests that a rich social network helps people reduce their risk of death about as much as avoiding cigarettes (Source: TIME.com: Top Science and Health Stories) ]]></description>
			<content:encoded><![CDATA[<p>A large new meta-analysis suggests that a rich social network helps people reduce their risk of death about as much as avoiding cigarettes (Source: TIME.com: Top Science and Health Stories) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/27/recipe-for-longevity-no-smoking-and-lots-of-friends/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biochemical and analytical development of the CIME cocktail for drug fate assessment in humans.</title>
		<link>http://medsnetic.com/blog/2010/07/27/biochemical-and-analytical-development-of-the-cime-cocktail-for-drug-fate-assessment-in-humans/</link>
		<comments>http://medsnetic.com/blog/2010/07/27/biochemical-and-analytical-development-of-the-cime-cocktail-for-drug-fate-assessment-in-humans/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 22:27:35 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280269475</guid>
		<description><![CDATA[We report here the first steps of the development of the innovative CIME cocktail. This cocktail is designed not only for the major cytochrome P450, with caffeine, amodiaquine, tolbutamide, omeprazole, dextromethorphan and midazolam as substrates of CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6 and CYP3A, respectively, but also phase II enzymes UGT 1A1/6/9 with acetaminophen, P-gp and OATP1B1 with digoxin and rosuvastatin, and renal function with memantine. An assay combining ultra-performance liquid chromatography using a 1.7 microm particle size column with tandem mass spectrometry (UPLC/MS/MS) was set up for the simultaneous quantification of the 20 substrates and metabolites after extraction from human plasma using solid-phase extraction. The method was validated in the spirit of the FDA gui... ]]></description>
			<content:encoded><![CDATA[<p>We report here the first steps of the development of the innovative CIME cocktail. This cocktail is designed not only for the major cytochrome P450, with caffeine, amodiaquine, tolbutamide, omeprazole, dextromethorphan and midazolam as substrates of CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6 and CYP3A, respectively, but also phase II enzymes UGT 1A1/6/9 with acetaminophen, P-gp and OATP1B1 with digoxin and rosuvastatin, and renal function with memantine. An assay combining ultra-performance liquid chromatography using a 1.7 microm particle size column with tandem mass spectrometry (UPLC/MS/MS) was set up for the simultaneous quantification of the 20 substrates and metabolites after extraction from human plasma using solid-phase extraction. The method was validated in the spirit of the FDA gui&#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/27/biochemical-and-analytical-development-of-the-cime-cocktail-for-drug-fate-assessment-in-humans/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma</title>
		<link>http://medsnetic.com/blog/2010/07/27/phase-1-trial-of-bortezomib-plus-r-chop-in-previously-untreated-patients-with-aggressive-non-hodgkin-lymphoma/</link>
		<comments>http://medsnetic.com/blog/2010/07/27/phase-1-trial-of-bortezomib-plus-r-chop-in-previously-untreated-patients-with-aggressive-non-hodgkin-lymphoma/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 22:11:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280268000</guid>
		<description><![CDATA[Bortezomib has preclinical and clinical in B-cell lymphomas, both alone and in combination with other agents. A phase 1 evaluation was conducted of bortezomib with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with untreated diffuse large B-cell lymphoma (DLBCL) or mantle cell lymphoma (MCL).Twenty patients (16 with DLBCL and 4 with MCL) with a median age of 66 years (range, 29-84 years) were enrolled. Eleven subjects (55%) had an elevated lactate dehydrogenase level, and 10 patients (50%) had International Prognostic Index scores of 3 to 5. Standard R-CHOP was administered on a 21-day cycle for 6 cycles, with 1 of 3 dose levels of bortezomib (0.7 mg/m2 [n = 4 patients], 1.0 mg/m2 [n = 9 patients], or 1.3 mg/m2 [n = 7 patients]) administered... ]]></description>
			<content:encoded><![CDATA[<p>Bortezomib has preclinical and clinical in B-cell lymphomas, both alone and in combination with other agents. A phase 1 evaluation was conducted of bortezomib with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with untreated diffuse large B-cell lymphoma (DLBCL) or mantle cell lymphoma (MCL).Twenty patients (16 with DLBCL and 4 with MCL) with a median age of 66 years (range, 29-84 years) were enrolled. Eleven subjects (55%) had an elevated lactate dehydrogenase level, and 10 patients (50%) had International Prognostic Index scores of 3 to 5. Standard R-CHOP was administered on a 21-day cycle for 6 cycles, with 1 of 3 dose levels of bortezomib (0.7 mg/m2 [n = 4 patients], 1.0 mg/m2 [n = 9 patients], or 1.3 mg/m2 [n = 7 patients]) administered&#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/27/phase-1-trial-of-bortezomib-plus-r-chop-in-previously-untreated-patients-with-aggressive-non-hodgkin-lymphoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Proposed FDA Plan on Prescription Drugs Rejected</title>
		<link>http://medsnetic.com/blog/2010/07/27/proposed-fda-plan-on-prescription-drugs-rejected/</link>
		<comments>http://medsnetic.com/blog/2010/07/27/proposed-fda-plan-on-prescription-drugs-rejected/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 21:49:34 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280264974</guid>
		<description><![CDATA[A lack of mandated training for physicians has helped sink a U.S. Food and Drug Administration (FDA) proposal intended to curb misuse of prescription drugs. (Source: Alcohol, Tobacco and Other Drugs News) ]]></description>
			<content:encoded><![CDATA[<p>A lack of mandated training for physicians has helped sink a U.S. Food and Drug Administration (FDA) proposal intended to curb misuse of prescription drugs. (Source: Alcohol, Tobacco and Other Drugs News) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/27/proposed-fda-plan-on-prescription-drugs-rejected/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New health policy: encouraging friendships?</title>
		<link>http://medsnetic.com/blog/2010/07/27/new-health-policy-encouraging-friendships/</link>
		<comments>http://medsnetic.com/blog/2010/07/27/new-health-policy-encouraging-friendships/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 21:11:53 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280264813</guid>
		<description><![CDATA[WASHINGTON (Reuters) - Having good social relationships -- friends, marriage or children -- may be every bit as important to a healthy lifespan as quitting smoking, losing weight or taking certain medications, U.S. researchers reported on Tuesday. (Source: Reuters: Health)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target ="_self">MedMatcha, MedWorm's medical advertising network</a></b>, and receive $5 free advertising.</p></div> ]]></description>
			<content:encoded><![CDATA[<p>WASHINGTON (Reuters) &#8211; Having good social relationships &#8212; friends, marriage or children &#8212; may be every bit as important to a healthy lifespan as quitting smoking, losing weight or taking certain medications, U.S. researchers reported on Tuesday. (Source: Reuters: Health)
<div id="medworm">
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target ="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/27/new-health-policy-encouraging-friendships/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Smoking may worsen outcome of pregnancy complication</title>
		<link>http://medsnetic.com/blog/2010/07/27/smoking-may-worsen-outcome-of-pregnancy-complication/</link>
		<comments>http://medsnetic.com/blog/2010/07/27/smoking-may-worsen-outcome-of-pregnancy-complication/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 21:10:25 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280261725</guid>
		<description><![CDATA[NEW YORK (Reuters Health) - A new study suggests that smokers who develop preeclampsia during pregnancy are at particular risk of suffering the complications associated with the disorder -- including preterm delivery, low birth weight and stillbirth. (Source: Reuters: Health) ]]></description>
			<content:encoded><![CDATA[<p>NEW YORK (Reuters Health) &#8211; A new study suggests that smokers who develop preeclampsia during pregnancy are at particular risk of suffering the complications associated with the disorder &#8212; including preterm delivery, low birth weight and stillbirth. (Source: Reuters: Health) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/27/smoking-may-worsen-outcome-of-pregnancy-complication/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Business health group saving costs</title>
		<link>http://medsnetic.com/blog/2010/07/27/business-health-group-saving-costs/</link>
		<comments>http://medsnetic.com/blog/2010/07/27/business-health-group-saving-costs/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 20:44:18 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280260218</guid>
		<description><![CDATA[New data released by the Business Health Care Group shows that the groupÃ¢ÂÂs self-funded member companies saw a four-year aggregate health care cost decrease of 5.4 percent per health plan member when compared with 2005 base-year costs. (Source: bizjournals.com Health Care:Health Insurance headlines) ]]></description>
			<content:encoded><![CDATA[<p>New data released by the Business Health Care Group shows that the groupÃ¢ÂÂs self-funded member companies saw a four-year aggregate health care cost decrease of 5.4 percent per health plan member when compared with 2005 base-year costs. (Source: bizjournals.com Health Care:Health Insurance headlines) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/27/business-health-group-saving-costs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Transition of kidney tubule cells to a senescent phenotype in early experimental diabetes</title>
		<link>http://medsnetic.com/blog/2010/07/27/transition-of-kidney-tubule-cells-to-a-senescent-phenotype-in-early-experimental-diabetes/</link>
		<comments>http://medsnetic.com/blog/2010/07/27/transition-of-kidney-tubule-cells-to-a-senescent-phenotype-in-early-experimental-diabetes/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 20:43:03 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280260983</guid>
		<description><![CDATA[Diabetic nephropathy is the commonest cause of end-stage renal disease. Inordinate kidney growth and glomerular hyperfiltration at the very early stages of diabetes are putative antecedents to this disease. The kidney is the only organ that grows larger with the onset of diabetes mellitus, yet there remains confusion about the mechanism and significance of this growth. Here we show that kidney proximal tubule cells in culture transition to senescence in response to oxidative stress. We further determine the temporal expression of G1 phase cell cycle components in rat kidney cortex at days 4 and 10 of streptozotocin diabetes to evaluate changes in this growth response. In diabetic rats we observe increases in kidney weight-to-body weight ratios correlating with increases in expression of th...<div id="medworm"><p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target ="_self">MedMatcha, MedWorm's medical advertising network</a></b>, and receive $5 free advertising.</p></div> ]]></description>
			<content:encoded><![CDATA[<p>Diabetic nephropathy is the commonest cause of end-stage renal disease. Inordinate kidney growth and glomerular hyperfiltration at the very early stages of diabetes are putative antecedents to this disease. The kidney is the only organ that grows larger with the onset of diabetes mellitus, yet there remains confusion about the mechanism and significance of this growth. Here we show that kidney proximal tubule cells in culture transition to senescence in response to oxidative stress. We further determine the temporal expression of G1 phase cell cycle components in rat kidney cortex at days 4 and 10 of streptozotocin diabetes to evaluate changes in this growth response. In diabetic rats we observe increases in kidney weight-to-body weight ratios correlating with increases in expression of th&#8230;
<div id="medworm">
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target ="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/27/transition-of-kidney-tubule-cells-to-a-senescent-phenotype-in-early-experimental-diabetes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A calcium-induced calcium release mechanism supports luteinizing hormone-induced testosterone secretion in mouse Leydig cells</title>
		<link>http://medsnetic.com/blog/2010/07/27/a-calcium-induced-calcium-release-mechanism-supports-luteinizing-hormone-induced-testosterone-secretion-in-mouse-leydig-cells/</link>
		<comments>http://medsnetic.com/blog/2010/07/27/a-calcium-induced-calcium-release-mechanism-supports-luteinizing-hormone-induced-testosterone-secretion-in-mouse-leydig-cells/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 20:05:03 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280260983</guid>
		<description><![CDATA[Leydig cells are responsible for the synthesis and secretion of testosterone, processes controlled by luteinizing hormone (LH). Binding of LH to a G protein-coupled receptor in the plasma membrane results in an increase in cAMP and in intracellular Ca2+ concentration ([Ca2+]i). Here we show, using immunofluorescence, that Leydig cells express ryanodine receptors (RyRs) and inositol 1,4,5-trisphosphate receptors (IP3Rs). Measurements of intracellular calcium changes using the fluorescent calcium-sensitive dye fluo-3 and confocal microscopy show that both types of receptors are involved in a calcium-induced calcium release (CICR) mechanism, which amplifies the initial Ca2+ influx through plasma membrane T-type calcium channels (CaV3). The RyRs and IP3Rs are functional, as judged from both th... ]]></description>
			<content:encoded><![CDATA[<p>Leydig cells are responsible for the synthesis and secretion of testosterone, processes controlled by luteinizing hormone (LH). Binding of LH to a G protein-coupled receptor in the plasma membrane results in an increase in cAMP and in intracellular Ca2+ concentration ([Ca2+]i). Here we show, using immunofluorescence, that Leydig cells express ryanodine receptors (RyRs) and inositol 1,4,5-trisphosphate receptors (IP3Rs). Measurements of intracellular calcium changes using the fluorescent calcium-sensitive dye fluo-3 and confocal microscopy show that both types of receptors are involved in a calcium-induced calcium release (CICR) mechanism, which amplifies the initial Ca2+ influx through plasma membrane T-type calcium channels (CaV3). The RyRs and IP3Rs are functional, as judged from both th&#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/27/a-calcium-induced-calcium-release-mechanism-supports-luteinizing-hormone-induced-testosterone-secretion-in-mouse-leydig-cells/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Adding Noninsulin Antidiabetic Drugs to Metformin Therapy for Type 2 Diabetes [Letters]</title>
		<link>http://medsnetic.com/blog/2010/07/27/adding-noninsulin-antidiabetic-drugs-to-metformin-therapy-for-type-2-diabetes-letters/</link>
		<comments>http://medsnetic.com/blog/2010/07/27/adding-noninsulin-antidiabetic-drugs-to-metformin-therapy-for-type-2-diabetes-letters/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 19:06:04 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280256664</guid>
		<description><![CDATA[(Source: JAMA) ]]></description>
			<content:encoded><![CDATA[<p>(Source: JAMA) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/27/adding-noninsulin-antidiabetic-drugs-to-metformin-therapy-for-type-2-diabetes-letters/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Tobacco Funds Dwindle as Obesity Fight Intensifies</title>
		<link>http://medsnetic.com/blog/2010/07/27/tobacco-funds-dwindle-as-obesity-fight-intensifies/</link>
		<comments>http://medsnetic.com/blog/2010/07/27/tobacco-funds-dwindle-as-obesity-fight-intensifies/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 18:52:35 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280253455</guid>
		<description><![CDATA[As public health priorities shift, anti-tobacco programs are losing out to the campaign against obesity. (Source: NYT Health) ]]></description>
			<content:encoded><![CDATA[<p>As public health priorities shift, anti-tobacco programs are losing out to the campaign against obesity. (Source: NYT Health) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/27/tobacco-funds-dwindle-as-obesity-fight-intensifies/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Extended use of anti-clotting drug helps some bedridden patients</title>
		<link>http://medsnetic.com/blog/2010/07/27/extended-use-of-anti-clotting-drug-helps-some-bedridden-patients/</link>
		<comments>http://medsnetic.com/blog/2010/07/27/extended-use-of-anti-clotting-drug-helps-some-bedridden-patients/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 17:53:00 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280250000</guid>
		<description><![CDATA[A treatment plan used to prevent potentially dangerous blood clots in recovering surgical patients can also benefit some patients immobilized by acute medical illness, doctors have found in a multi-institutional study. (Source: ScienceDaily Headlines)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target ="_self">MedMatcha, MedWorm's medical advertising network</a></b>, and receive $5 free advertising.</p></div> ]]></description>
			<content:encoded><![CDATA[<p>A treatment plan used to prevent potentially dangerous blood clots in recovering surgical patients can also benefit some patients immobilized by acute medical illness, doctors have found in a multi-institutional study. (Source: ScienceDaily Headlines)
<div id="medworm">
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target ="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/27/extended-use-of-anti-clotting-drug-helps-some-bedridden-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Good early results for herpes vaccine</title>
		<link>http://medsnetic.com/blog/2010/07/27/good-early-results-for-herpes-vaccine/</link>
		<comments>http://medsnetic.com/blog/2010/07/27/good-early-results-for-herpes-vaccine/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 17:47:03 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:usa-drug-shop.com://post.1280250423</guid>
		<description><![CDATA[Antigenics says it has achieved positive results in an early stage human trial for a potential herpes vaccine. A vaccine, if approved, would be a blockbuster pharmaceutical product Ã¢ÂÂ 60 million Americans are infected with herpes simplex virus-2, more commonly known as genital herpes. (Source: bizjournals.com Health Care:Health Insurance headlines) ]]></description>
			<content:encoded><![CDATA[<p>Antigenics says it has achieved positive results in an early stage human trial for a potential herpes vaccine. A vaccine, if approved, would be a blockbuster pharmaceutical product Ã¢ÂÂ 60 million Americans are infected with herpes simplex virus-2, more commonly known as genital herpes. (Source: bizjournals.com Health Care:Health Insurance headlines) </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/27/good-early-results-for-herpes-vaccine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mesothelioma-Causing Asbestos May be Banned in the United States</title>
		<link>http://medsnetic.com/blog/2010/07/27/mesothelioma-causing-asbestos-may-be-banned-in-the-united-states/</link>
		<comments>http://medsnetic.com/blog/2010/07/27/mesothelioma-causing-asbestos-may-be-banned-in-the-united-states/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 16:07:59 +0000</pubDate>
		<dc:creator>drugs</dc:creator>
				<category><![CDATA[Drugs]]></category>

		<guid isPermaLink="false">tag:://post.1280244779</guid>
		<description><![CDATA[According to a recent report, the Environmental Protection Agency (EPA) has plans to phase out the use of asbestos within the next decade.
Lin Chien-hui, director of the EPA&#8217;s Department of Environmental Sanitation and Toxic Substance Management, said the ban on asbestos will be enforced through two stages.
On July 1, 2015, regulations will be in place to make sure asbestos is no longer used as a sealing material in construction projects. On July 1, 2020, asbestos will be banned for all uses in tiles, linings and extruded cement panels.
The plan to ban asbestos in the United States marks a big step towards lowering the risk of developing asbestos-related diseases. One of these conditions is malignant mesothelioma, a rare form of cancer almost exclusively caused by asbestos exposure. ... ]]></description>
			<content:encoded><![CDATA[<p>According to a recent report, the Environmental Protection Agency (EPA) has plans to phase out the use of asbestos within the next decade.<br />
Lin Chien-hui, director of the EPA&#8217;s Department of Environmental Sanitation and Toxic Substance Management, said the ban on asbestos will be enforced through two stages.<br />
On July 1, 2015, regulations will be in place to make sure asbestos is no longer used as a sealing material in construction projects. On July 1, 2020, asbestos will be banned for all uses in tiles, linings and extruded cement panels.<br />
The plan to ban asbestos in the United States marks a big step towards lowering the risk of developing asbestos-related diseases. One of these conditions is malignant mesothelioma, a rare form of cancer almost exclusively caused by asbestos exposure. &#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://medsnetic.com/blog/2010/07/27/mesothelioma-causing-asbestos-may-be-banned-in-the-united-states/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
